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Abstract 
The purpose of this cross-sectional, secondary data analysis was to explore, non-modifiable 
(stable) trait factors and modifiable (transient) state factors associated with fear of recurrence 
(FOR) in breast cancer survivors. Antecedent trait factors included demographic, clinical, 
social/behavioral factors, postulated mediator state factors included pain, fatigue, sleep 
disturbances, depression, state anxiety and perceived stress, and FOR was the outcome variable. 
The study used baseline data from an R-21 NCI funded (grant #R21CA109168) randomized 
control trial that examined the effects of mindfulness based stress reduction in early stage breast 
cancer recovery.  Instruments from this study for antecedent variables (trait factors) included a 
Demographic and Clinical History Form, STAI; instruments used for mediator variable (state 
factors) included CES-D, STAI, PSS and MDASI subscales for pain and fatigue, sleep; the 
instruments used for the outcome variable FOR - CARS overall fear and nature of worry.  The 
study sample included 82 women within 18 months post breast cancer treatment (stage 0, I, II, 
III). The Theoretical Model for psychosocial nursing research was used as a heuristic framework 
to examine the associations between trait factors and state factors and their mediating effects on 
FOR.  Aim 1 explored the relationship between the antecedent (trait) variables associated with 
FOR (CARS overall fear and CARS nature of worry) using Pearson’s and Spearman’s 
correlations and analysis of variance (ANOVA). The findings revealed a negative association 
between age and FOR, CARS overall fear (r = -.236, p = .033) and FOR, CARS nature of worry 
(r = -.269, p = .015).  Trait anxiety was positively associated with FOR, CARS overall fear (r = 
.433, p = .000) and FOR, CARS nature of worry (r = .358, p < 0.001).  Race/ethnicity, education, 
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marital status, employment, exercise, cancer stage, cancer treatment, exercise, smoking, 
drinking, hormone use and family history of breast cancer were not  associated with FOR.  Aim 
2 explored the relationship between postulated mediator (state) variables, such as pain, fatigue, 
sleep disturbances, state anxiety, depression, perceived stress associated with FOR (CARS 
overall fear and CARS nature of worry) using Pearson’s correlations. Findings revealed that 
depression (r = .347, p = .001), state anxiety (r = .467, p < 0.001), perceived stress (r = .365, p = 
.001) were positively associated with FOR, CARS overall fear of recurrence, and that pain (r = 
.220, p = .047), fatigue (r = .247, p = .025), state anxiety (r = .369, p = .001), and perceived 
stress (r = .410, p < 0.001) were positively associated with FOR, CARS nature of worry. Aim 3 
used a mediation analysis (bootstrapping method) to examine the indirect effects of the 
statistically significant modifiable mediator state factors on the statistically significant antecedent 
trait factors and FOR (CARS overall fear and CARS nature of worry). With trait anxiety as the 
antecedent variable, state anxiety was indirectly associated (a mediating variable) with FOR, 
CARS overall fear (β = .1381, 95% CI = .0053 - .3050, p = .0299). Similarly, with a composite 
age/trait anxiety antecedent variable, state anxiety was indirectly associated (a mediating 
variable) with FOR, CARS overall fear (β = .5579, 95% CI = .1201 - 1.1669, p = .0157).  
Perceived stress and depression did not mediate the relationship between age and trait anxiety 
and concerns about recurrence overall fear. With trait anxiety as the antecedent variable, 
perceived stress was indirectly associated (a mediating variable) with FOR, CARS nature of 
worry (β = .5474, 95% CI = .0178 - 1.3298, p = .0294). Similarly, a composite age/trait anxiety 
antecedent variable, perceived stress was indirectly associated (a mediating variable) with FOR, 
CARS nature of worry (β = 2.0375, 95% CI = .1136 - 4.5976, p = .0495).  Pain, fatigue and state 
anxiety did not mediate the relationship between age and trait anxiety and FOR nature of worry.  
 
 
ix 
This study suggests that breast cancer survivors who are anxious at baseline and report a current 
state of anxiety or perceived stress may be at higher risk for fears of breast cancer recurrence. 
Understanding the individual patient characteristics such as age, history of anxiety and current 
status of perceived stress or anxiety and the relationship with fears of recurrence allow nurses to 
offer individualized interventions for patients at greatest risk for psychological distress.   
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Chapter One 
Introduction 
Breast cancer is the second leading cause of cancer in women and survivors comprise the 
largest population of cancer survivors in the United States (National Cancer Institute, 2013).  In 
2013 there were estimated to be 232,340 new breast cancer cases in women (National Cancer 
Institute, 2013). There have been tremendous growth advancements in the screening, diagnosis 
and treatment of breast cancer that has changed the trajectory of breast cancer management with 
a major focus on survivorship. A factor contributing to improving the morbidity in breast cancer 
survivorship is through optimal management of psychological health and well-being.  The 
psychological needs of breast cancer survivors vary across the disease and demographic 
spectrum.  However, one of the most prevalent and consistent psychological stressors is the ever-
looming fear of cancer recurrence (FOR). Although there have been advances in early diagnosis 
and treatment of breast cancer, managing post-treatment psychological distress has proven to be 
particularly challenging.  The sequelae from the diagnosis and treatment of breast cancer and the 
lingering threats of fear of cancer recurrence create long-term complications and impaired 
quality of life for breast cancer survivors (Wong & Bramwell, 1992). The findings from this 
study provides valuable data to assist health care providers with a better understanding of those 
women who may be at greatest risk for worries about recurrence, the factors that are most 
associated with fear of cancer recurrence and the effects of the interactions between those 
factors.  
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Statement of the Problem 
The most current data from the National Cancer Institute 2009/2010 Progress Report 
estimates 12 million cancer survivors in the United States in 2008 with breast cancer survivors 
making up the largest population of 2.8 million survivors with 12.29% (or 1 in 8) of the women 
born today will be diagnosed with some form of breast cancer in their lifetime (National Cancer 
Institute, 2013).  Breast cancer rates have increased since the early 1990’s, however in spite of 
this, survival rates have continued to climb over the past 20 years partly due to advances in 
breast cancer screening, early diagnosis and aggressive treatment modalities (National Cancer 
Institute, 2013).   During 2004-2008, the median age at the time of breast cancer diagnosis was 
61 years indicating that 50% of women who developed breast cancer were 61 years of age or 
younger at the time of diagnosis (Howlader et al., 2011).  According to the American Cancer 
Society (2012), women with breast cancer have an 89% survival rate after 5 years of diagnosis, 
82% after 10 years and 77% after 15 years.  Thus, the majority of breast cancer patients survive 
an extended period of time after treatment.  Since 1975, the breast cancer 5-year relative survival 
rate has increased significantly for both African American and Caucasian women with a survival 
rate of 77% for African American women and 90% among White women (Howlader et al., 
2011). The survival rate for women diagnosed before age 40 is 84% and 90% in women 
diagnosed after age 40 (American Cancer Society, 2012).  Breast cancer patients from lower- 
income areas have lower 5-year survival rates than those from higher-income areas at every stage 
of diagnosis (Harper et al., 2009).  
The diagnosis and treatment of breast cancer along with the side effects of pain, fatigue 
and anxiety and the lingering threats of fear of cancer recurrence create dysregulation of 
psychological and physiologic mechanisms (Luecken & Compas, 2002; McGregor & Antoni, 
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2009; Reich, Lesur & Perdrizet-Chevallier, 2008). About 30-40% of patients experience elevated 
symptoms of anxiety and depression at the time of breast cancer diagnosis and although some of 
these symptoms dissipate over time, there is a subset of women who continue to experience 
psychological distress throughout their treatment and recovery, with 3-30% continuing to exhibit 
signs of moderate to severe emotional distress (Andrykowski, Cordova, Studts, & Miller, 1998; 
Carver et al., 1993; Cordova et al., 1995; Epping-Jordan et al., 1999; Luecken & Compas, 2002; 
Reich, et al., 2008).  This is an important finding because much of the earlier research has 
focused on early intervention to address distress in the acute phase of breast cancer treatment but 
interventions for fear of recurrence has long-term implications requiring more long-term 
interventions (Lengacher et al., 2009). The previous emphasis on early detection, different 
treatment modalities and cancer prevention has led to increased survivorship therefore 
warranting current and future research efforts to focus on the physical, psychological and 
economic factors associated with quality of life and well-being in survivorship (Baker, 
Denniston, Smith & West, 2005). 
Non-Modifiable Trait Factors Associated with FOR 
Age is the one factor that is consistently described in the literature as being strongly 
associated with fear of recurrence.  The relationship of age and fear of recurrence was found to 
be a common theme throughout the literature however, the parameters that define younger and 
older patients varies greatly throughout the reviewed literature. Younger age (< 40 years) was 
found to have more intense fears of cancer recurrence than women who were diagnosed at an 
older age (>40 years) (Costanzo et al, 2007; Simard & Savard, 2009; Van den Beuken-van 
Everdigen et al., 2008; Vickberg, 2003; Wade, Nehmy & Koczwara, 2005; Waljee et al., 2008).  
This may be partly due to the slightly lower 5-year survival rate and the severity of the cancer 
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diagnosis earlier than age 40; with this comes a greater sense of loss due to work opportunities, 
childbearing, raising children and lost future opportunities (Wade et al., 2005).  
Vickberg (2003) discovered that younger age was the strongest predictor of fear of 
recurrence and the greatest predictor of distress of fear of recurrence for ages 32-47 years (p < 
0.001) (Costanzo et al., 2007).  This is consistent with other studies that identified age as a factor 
related to adjustment in older women who reported less fear of recurrence (p<0.05) at 1-year 
(Stanton, Danoff-Burg, & Burg, 2002); and at time of diagnosis and at their 2-year follow-up 
than the younger breast cancer survivors (Liu et al., 2011; Van den Beuken-van Everdingen et 
al., 2008).     
Modifiable State Factors Associated with Fear of Recurrence 
Triggers of fear of breast cancer recurrence were consistent among the reviewed studies.  
Of all the triggers identified, pain was reported to be the most frequent trigger for fear of cancer 
recurrence in breast cancer survivors (Gil et al., 2004; Mast, 1998; Mishel, Germino, & Gil, 
2005; Van den Beuken-van Everdigen et al., 2008).   Mishel et al., (2005) studied the efficacy of 
an uncertainty management intervention in 509 North Carolina Caucasian and African- 
American, older, long-term breast cancer survivors (5-9 years survivorship) and found that the 
threat of recurrence endures over time.  These women reported at least two physical or emotional 
triggers per month (16 triggers over the course of the 8 months); although the reminders were not 
constant they persisted over time and the cancer awareness remained continually in their 
consciousness (Mishel et al., 2005). 
Fear of Recurrence  
 One of the major causes of distress in breast cancer survivors is uncertainty of the future 
or fear of cancer recurrence (Lee-Jones, Humphries, Dixon, & Hatcher, 1997; Wong & 
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Bramwell, 1992).  Fear of cancer recurrence can be the cause of distress in survivors or it can be 
the end result of a variety of post-cancer related stressors. Several studies support this theory and 
suggest that there is a bidirectional relationship between fear of cancer recurrence and emotional 
distress; in some cases distress (anxiety, depression, fatigue) may precipitate fear of recurrence 
(Lebel, Rosberger, Edgar, & Devins, 2009; Lee-Jones et al., 1997) or perhaps fear of recurrence 
may precipitate the distress (Black & White, 2005; Deimling et al., 2006).   Regardless of the 
direction of the pathway several studies have reported a high prevalence of moderate to high fear 
of recurrence.  Vickberg (2003) reported a fear of recurrence prevalence of 55% (n=169) among 
breast cancer survivors.  Van den Beuken-van Everdingen et al. (2008) found 56% (n=136) up to 
4 years post treatment and in an earlier study of survivors 5 years after diagnosis, as many as 
70% of breast cancer survivors continued to have fears of cancer recurrence (Mast, 1998).  Most 
breast cancer survivors reported moderate cancer related anxiety, concerns about ongoing 
physical symptoms and fear of cancer recurrence as their top sources of distress during multiple 
points in their treatment and beyond (as far out as 2-years) (Costanzo et al., 2007; Liu et al., 
2011; Stephens et al., 2008).  Lee-Jones et al. (1997) identified several precipitating factors that 
influence fear of recurrence.  These factors included the survivor’s perspective that periods of 
emotional distress may directly impact their cancer recurrence, due to symptoms of fatigue or 
pain interpreted as signs of cancer recurrence, or emotional distress which may heighten the 
patient’s sensitivity to their physical symptoms resulting in fear of recurrence (Lee-Jones et al., 
1997).  Connell, Patterson, and Newman (2006) reported that fear of recurrence was a major 
concern for many of their study participants (54%) and a top concern among younger women < 
41 years (31.5%).  With the numbers of breast cancer survivors continuing to grow, it is 
imperative to understand the factors that will influence breast cancer survivorship.  Stress, both 
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physical and psychological, are critical factors influencing the immunity in breast cancer quality 
of life and morbidity (Andersen et al., 2008; Chrousos, 2000; Keicolt-Glaser, McGuire, Robles, 
& Glaser, 2002; Witek-Janusek, Gabram, & Mathews, 2007). Considerations identified also pose 
valuable questions regarding the need to identify a standardized definition for clinical levels of 
fear of recurrence, defining pathological characteristics and levels for fear of recurrence, routine 
screening and identifying indicators for clinical interventions (Thewes et al., 2012). 
The findings from this study provide valuable data to support the understanding of those 
factors most associated with fear of recurrence, particularly those factors that have the potential 
mediating effect on fear of recurrence. Outcomes from this research can support future studies 
that will focus on bio-behavioral associations with fear of recurrence, stress related biomarkers 
and the effects of early screening and interventions.  This is consistent with the recommendations 
from a study performed by Lebel et al., (2009) suggesting that future research should evaluate 
the prevalence of comorbid disorders (anxiety, depression, perceived stress) in cancer patients 
who report high fear of recurrence.  
Purpose of the Study 
The purpose of this study was to examine the antecedent, non-modifiable (stable) trait 
factors most associated with fear of breast cancer recurrence and the mediating effects of 
modifiable (transient) state factors associated with fear of cancer recurrence.  This study, a 
secondary data analysis, used baseline data from an R-21 NCI funded (grant #R21CA109168) 
randomized control trial that examined the effects of mindfulness based stress reduction in early 
stage breast cancer recovery (Lengacher et al., 2009).  The first aim was to examine the 
relationship between stable, non-modifiable trait factors (antecedent variables demographic 
factors such as age, ethnicity/race, marital status, education, employment status), clinical history 
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(stage of cancer at diagnosis, treatment history, hormone use, family history of breast cancer and 
trait anxiety), social/behavioral history (drinking, smoking, exercise history) and the outcome 
variable (fear of breast cancer recurrence).  Additionally, the study explored the relationship 
between modifiable state factors (mediator variable such as state anxiety, depression, perceived 
stress, pain, fatigue and sleep disturbances) considered to be transient and the outcome variable 
fear of breast cancer recurrence. The antecedent trait factors associated with FOR and the 
mediator state factors found to be most associated with fear of breast cancer recurrence were 
studied by examining the potential mediating effects of those state factors on the trait factors 
associated with fear of breast cancer recurrence. Understanding the relationship between trait 
factors associated with fear of breast cancer recurrence that can be mediated by certain state 
factors most associated with fear of recurrence can inform health care professionals to directly 
target and prioritize interventions towards those women at risk for psychological distress during 
survivorship.   
Aims 
The aims of this study were to:  
1) Examine the relationship between the antecedent variables (non-modifiable (stable) 
trait factors) including age, ethnicity/race, marital status, education, employment status, stage of 
cancer at diagnosis, treatment history, history of smoking, drinking, exercise, hormone use, 
family history of breast cancer and trait anxiety associated with the outcome variable, fear of 
breast cancer recurrence (CARS overall fear and CARS nature of worry);  
2) Examine the relationship between the mediator variables (modifiable (transient) state 
factors) including state anxiety, depression, perceived stress, pain, fatigue and sleep disturbances 
associated with the outcome variable, fear of breast cancer recurrence;   
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3) Examine those state factors that mediate the relationship between trait factors 
(antecedent variables) associated with fear of breast cancer recurrence (outcome variable). 
Definition of Terms 
The antecedent, mediator and outcome variables used in this study are outlined and defined 
specifically in this section.  For the purposes of this study, the following definitions were used: 
1. Non-modifiable trait factors (antecedent variables):  Those trait characteristics that cannot 
be modified or are not easily modifiable and are stable over time including (age, 
ethnicity/race, marital status, education, employment status, stage of cancer at diagnosis, 
treatment history, history of smoking, drinking, exercise, hormone use, family history of 
breast cancer and trait anxiety).  
a. Trait anxiety: Defined as the general tendency to respond to perceived threats 
with anxiety (Spielberger, Gorsuch, & Luschene, 1983).   
2. Modifiable state factors (mediator variables):  Those physiological states (pain, fatigue, 
sleep disturbances) and psychological states (depression, perceived stress, state anxiety) 
that is transient and may be modified through interventions.  State is defined as a mode, 
condition or stage in the physical being of something (Merriam-Webster, 2012).  
a. Pain:  Defined as an unpleasant subjective sensory and emotional experience 
associated with actual or potential tissue damage (International Association for 
the Study of Pain, 2013). 
b. Fatigue: Defined as “a subjective state of overwhelming and sustained exhaustion 
with a decrease in capacity for physical and mental work not relieved with rest” 
(Cella, Peterman, Passik, Jacobsen & Breitbart, 1998, p. 369).   
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c. Sleep disturbances:  Difficulty falling asleep, staying asleep, waking up too early, 
in ability to resume sleep or sleep that is non-restorative or poor in quality with 
sleepiness during the day (Berger, 2009).  
d. Depression: Subjective or observed depressed mood, feelings of guilt, 
worthlessness, hopelessness, helplessness, change in appetite, sleep disturbances, 
fatigue or loss of energy (Radloff, 1977).  
e. Perceived stress: The situations in one’s life that are appraised as stressful 
(Cohen, Kamarck & Mermelstein, 1983).   
f. State anxiety: The temporary emotional state that is characterized by conscious 
feelings of tension and apprehension and heightened autonomic system activity  
(Spielberger et al., 1983). 
3. Fear of breast cancer recurrence: Defined as fear that the breast cancer is coming back in 
the same breast or another area of the body, or a new breast cancer (Vickberg, 2003, 
p.18). The literature tends to use worry synonymously with fear in fear of recurrence 
(Vickberg, 2003). 
Delimitations 
 The sample included women who were post-treatment for breast cancer and included the 
following parameters: 
1. Ages 21 or older  
2. Diagnosed with breast cancer Stage 0, I, II, III and had undergone; lumpectomy and 
received adjuvant radiation and/or chemotherapy and were within 18 months post 
treatment;   
3. Able to read and speak English at an 8th grade level.  
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Assumptions 
 The assumptions of this study support the concept that there are multiple factors 
independently associated with higher levels of fear of breast cancer recurrence and several 
factors that mediate the effects of fear of breast cancer recurrence. Some of the factors that may 
be associated include age at time of diagnosis, stage of cancer at diagnosis, level of education, 
history of anxiety, depression and perceived stress. 
Significance of the Study 
The management of breast cancer does not end with the diagnosis and treatment of the 
disease and fear of breast cancer recurrence remains a persistent threat to cancer survivors. Many 
studies have explored various influences on fear of cancer recurrence in breast cancer survivors 
including demographic predictors, triggers, and emotional stressors (Gil et al., 2004; Lee-Jones, 
et al., 1997; Lengacher et al., 2009; Lengacher et al., 2011; Mast, 1998; Mishel et al., 2005; Van 
den Beuken-van Everdigen et al., 2008; Vickberg, 2003).  However, the existing research has not 
explored the mediating effects of modifiable state factors such as physical and psychological 
factors on stable, non-modifiable factors like age, education, stage of cancer, treatment, etc. and 
outcome of fear of cancer recurrence.  Understanding these relationships provides valuable 
information as health care providers attempt to individually tailor support and psychological 
interventions early in breast cancer treatment and survivorship, thus reducing unnecessary 
distress and promoting psychological health and well-being in breast cancer survivors. This 
study establishes a uniqueness of examining the mediating effects of transient, modifiable state 
factors on the relationship between stable, non-modifiable factors and fear of breast cancer 
recurrence that goes beyond the existing published research.  
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Chapter Two 
Literature Review 
Introduction 
 This chapter describes the theoretical model and framework and the empirical review of 
the literature. The theoretical framework provides the model guided the empirical review of the 
literature for the current research study.  The review of the literature focused on the prevalence 
of fear of recurrence in breast cancer survivorship and the main factors associated with fear of 
recurrence including specific demographic, clinical, social/behavioral, physiological and 
psychological concerns; this was followed by a summary of the findings.    
Theoretical Framework 
 The theoretical framework guiding this study was the Theoretical Logic Model for 
psychosocial nursing research (Evans, 1992).  This model was used as a heuristic framework to 
examine the associations between trait factors and state factors and the mediating effects on fear 
of breast cancer recurrence.  The logic model was designed to examine specific domains of 
interest, studying specific variables and hypothesized relationships among the variables or 
domains and the expected client outcomes (Evans, 1992). The model provided a sound 
framework for this study that supports the examination and identification of factors strongly 
associated with fear of breast cancer recurrence among breast cancer survivors. 
Hypothesized Logic Model 
 The Logic Model for psychosocial nursing research was adapted for this study (Evans, 
1992).  The inputs of the model are comprised of the study subject’s baseline stable, non-
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modifiable trait factors including demographic factors (age, race/ethnicity, education, marital 
status, employment), clinical history factors (stage of cancer at diagnosis, treatment type, 
hormone use, family history of breast cancer, history of trait anxiety) and social/behavioral 
history (exercise history, smoking and alcohol history).  
The proposed model explores three pathways as depicted in Figure 1.  The first pathway 
evaluates the relationship between the antecedent variables (non-modifiable trait factors) and 
outcome variable, fear of breast cancer recurrence (CARS overall fear and CARS nature of 
worry).  The second pathway evaluates the relationship between the mediator variables 
(modifiable state factors) and the outcome variable, fear of recurrence (CARS overall fear and 
CARS nature of worry). The antecedent and mediator variables strongly associated with fear of 
cancer recurrence comprise the third pathway, the model for mediation.  The mediation model 
explains how mediating variables (modifiable state factors) influence the relationship between 
the antecedent variables (non-modifiable trait factors) and the outcome variable, fear of 
recurrence. 
Review of Empirical Literature 
 The review of empiric literature for this study has been organized into several sections 
including: 1) non-modifiable trait factors associated with fear of breast cancer recurrence such as 
demographic factors (age, race/ethnicity, education, marital status, employment status), clinical 
factors (stage of cancer at diagnosis, treatment history, hormone use, family history of breast 
cancer, trait anxiety) and social/behavioral factors (exercise, smoking, alcohol use); 2) 
modifiable state factors such as physiologic factors (pain, fatigue, sleep disturbances) and 
psychological factors (depression, perceived stress, state anxiety), and 3) outcome variable fear 
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of recurrence (CARS overall fear and CARS nature of worry). Many of the variables related to 
fear of recurrence and breast cancer survivorship tend to be studied together as there tends to be 
some overlap or clustering of some of the symptoms associated with fear of recurrence therefore 
this review was organized into the categories most commonly studied in the literature.   
Figure 1. Biobehavioral Logic Model 
 
Note:  Trait factors are defined as non-modifiable factors that are stable over time and state 
factors are defined as modifiable (transient) factors that may be changed with interventions. 
 
Demographic/Clinical Factors – Age, Stage, Education, Treatment and Fear of 
Recurrence in Breast Cancer Survivors.  The research highlights several demographic factors 
 
 
14 
associated with fear of recurrence in breast cancer survivorship. The two most common 
demographic factors associated with fear of breast cancer recurrence in survivors are age and 
level of education.  
A quantitative study by Kornblith et al., (2007) of 252 breast and endometrial cancer 
survivors in Boston, Massachusetts explored differences in adjustment between younger and 
older survivors.  Using the Fear of Recurrence Scale findings confirmed that younger (< 55 
years) breast cancer survivors experienced higher FOR (p<0.0001) than older breast cancer 
survivors (> 65 years) at baseline and for all cancer survivors younger survivors had higher FOR 
after 1-year than the older women (p < 0.01) (Kornblith et al., 2007).  It was also noted that 
breast cancer survivors displayed significantly higher FOR than the endometrial cancer survivors 
regardless of their age (p<0.0001) (Kornblith et al., 2007).  
The interaction of threat appraisal and coping appraisal related to fear of recurrence was 
studied in a cross-sectional sample of 155 early stage breast cancer patients post-treatment 
(McGinty, Goldenberg & Jacobsen, 2010).  Fear of recurrence was measured using the modified 
Cancer Worry Scale (mCWS).  Younger age (r = -0.25, p < 0.01) and more advanced disease 
stage were the only variables that were significantly related to fear of recurrence (McGinty et al., 
2010). The interaction of age, disease stage, vulnerability and coping appraisal accounted for 
34% of the variance (p <0.001) (McGinty et al., 2010). Threat appraisal accounted for 30% of 
variance in fear of recurrence (p<0.001) and coping did not account for fear of recurrence, 0% 
(p=0.64) (McGinty et al., 2010).  However, those patients who reported high threat appraisal and 
low coping appraisal interaction experienced the highest levels of fear of recurrence (p = 0.04) 
(McGinty et al., 2010).  Women who reported high perceived vulnerability and low coping 
appraisal had the highest fear of recurrence (p < 0.02) (McGinty et al., 2010). 
 
 
15 
A 2006 study of women’s personal concerns in breast cancer survivorship was performed 
in a convenience sample of 35 Australian women age 40 years and younger that were within 4 
years of their breast cancer diagnosis (Connell et al., 2006).  The findings from this exploratory 
study using semi-structured interviews revealed that for younger women (20 – 40 years of age) 
showed fear of the future and cancer recurrence was the most common personal concern (54%) 
and the top-ranking perceived concern (31.5%) (Connell et al., 2006).  Twice as many the 
women who had a lumpectomy reported fear of recurrence as their major personal concern 
compared to those survivors that had a mastectomy (Connell et al., 2006). 
A study of 2290 women with non-metastatic breast cancer in Detroit and Los Angeles 
examined worry about recurrence related to race/ethnicity and health care experiences (Janz et 
al., 2011).  In the design of this study Latina and African Americans were oversampled (Janz et 
al., 2011).  Using a worry scale created by the researcher, findings revealed that low acculturated 
Latinas reported more worry than African Americans and Whites and African Americans 
reported significantly less worry than whites (p < 0.001) (Janz et al., 2011).  Women who were 
younger age, Latina, employed, married and less educated experienced greater worry (Janz et al., 
2011).  Persistent pain and fatigue and higher cancer stage during treatment indicated greater 
worry (Ps <0.05) (Janz et al., 2011).  Patient who had a lumpectomy, radiation and/or 
chemotherapy reported more worry compared to those that had a mastectomy (Ps<0.05) (Janz et 
al., 2011).   
A qualitative study of 18 Australian women post treatment (6-24 months) for early stage 
breast cancer was performed using telephone interviews (Thewes, Butow & Pendlebury, 2004).  
Pain and fatigue were reported most commonly as late effects of their treatment in the younger 
and older women (Thewes et al., 2004).  The women also reported the need to be assured that 
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their symptoms were normal and reassurance that it was not recurrence of their cancer (Thewes 
et al., 2004).  Many of the women reported fears physical symptoms would indicate that the 
cancer would return (Thewes et al., 2004).  Although most of the fears of recurrence did not 
impact quality of life, some of the younger women related their fears to the limited ability to plan 
for the future or to have children (Thewes et al., 2004).  It is important to note that some of the 
younger women reported that the information they received during and after treatment as not 
completely relevant to their needs, nor were the support groups relevant to the younger age 
(Thewes et al., 2004). Additionally they requested more information about complimentary 
therapies, diet, exercise and healthy living than the older women (Thewes et al., 2004). 
A prospective, descriptive study of 291 Australian breast cancer survivors was performed 
to examine characteristics associated with cancer treatments and impact on quality of life (King, 
Kenny, Hall, & Boyages, 2000).  Findings revealed that older women had better body image (p< 
0.0001), social and emotional functioning (p< 0.0001), experienced less pain (p< 0.00047) and 
fear of cancer recurrence (p < 0.0001) than younger women (King et al., 2000). Additionally, 
who more educated (vocational/tertiary education) reported less physical symptoms (p= 0.0001 
and p=0.0057), pain (p=0.0057) and better emotional (p=0.015) and physical (p=0.021) 
functioning than those breast cancer survivors with only secondary school education (King et al., 
2000).  In general quality of life dimensions for the younger women was less than their older 
counterparts (King et al., 2000). 
Australian women (N =218) ages 18-45 diagnosed with stage 0-2 breast cancer within 1-
year of diagnosis participated in a study examining women’s fears of breast cancer recurrence 
(Thewes et al., 2012). Using the Fear of Cancer Recurrence Inventory (FCRI), the researchers 
found associations between fear of cancer recurrence and frequency of self-breast exams, 
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doctor’s visits and complementary and alternative medicines (CAM).  Age at diagnosis was the 
only confounder associated with fear of cancer recurrence that was adjusted for and was found to 
be statistically significant (Thewes et al., 2012).  The total FCRI decreased by 1.3 for each 
additional year of age with a (95% CI -2.0, -6.9; p < 0.0001) (Thewes et al., 2012).  High fear of 
cancer recurrence has been associated with more unscheduled visits to the doctor, higher 
frequency of breast screening and cancer screening, counseling and support groups (Thewes et 
al., 2012).  In the same study women who had higher levels of fear of recurrence also used more 
CAM and spent more money on CAM (Thewes et al., 2012). Higher fear of recurrence was also 
associated with not having mammograms, ultrasounds or other cancer screening exams unlike 
those that reported receiving an ultrasound or mammogram in the past year experienced lower 
levels of fear of recurrence (Thewes et al., 2012). This study found that between 64% and 76% 
of young women with a history of early breast cancer reported clinical levels of fear of cancer 
recurrence demonstrating that younger women diagnosed with breast cancer are at greater risk 
for experiencing greater fear of cancer recurrence (Thewes et al., 2012). 
 A study of the efficacy of senior peer counseling by telephone for supplemental 
psychosocial support in a sample of 142 California women ages 50-94 that were newly 
diagnosed with breast cancer stage 0-3 was done in 2012 by Crane-Okada et al.  Using the Fear 
of Recurrence (FOR) scale by Northouse (1981) findings revealed that there was a significant 
main effect of age and fear of recurrence and community resource utilization (Crane-Okada et 
al., 2012).  Younger women reported a higher (  = 75.7, SD = 16.4) of fear of recurrence with a 
higher number of community resources used (  = 3.1, SD = 1.5) than the older women’s fear of 
cancer recurrence (  = 67.5, SD = 15.6) and resources used (  = 2.4, SD = 1.7) (Crane-Okada et 
al., 2012).  Another main effect at baseline that was significant was age; younger patients (aged 
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50-64 years) used coping by seeking support more than their older counterparts (Crane-Okada et 
al., 2012).  This was consistent at six months among the younger patients who were more likely 
to use coping strategies than the older participants (Crane-Okada et al., 2012).  At each time 
point during the study fear of recurrence was highest for those patients who were alone and 
anxious at baseline suggesting this group would be most in need of therapeutic interventions 
(Crane-Okada et al., 2012).  
A study of 714 breast cancer survivors who underwent breast-conserving therapy at the 
University of Michigan, Ann Arbor, Michigan found that approximately 27% of the women 
experienced high levels of fear of recurrence and 22% reported depressive symptoms (Waljee et 
al., 2008).  Younger women (< 40 years) reported feeling stigmatized from the treatment they 
received for their breast cancer (Waljee et al., 2008). Fear of recurrence was higher in women 
with pronounced breast asymmetry post breast cancer treatment opposed to women who 
experienced minimal and moderate asymmetry (pronounced asymmetry, 40.4%; minimal 
asymmetry, 19.8%; moderate asymmetry, 19.0%; Wald test = 21.5; p < 0.001) (Waljee et al., 
2008).  Patient age was also significantly related to fear of loss of health (p < .001) and disease 
stage was significantly associated with fear (p = 0.05) (Waljee et al., 2008).  
An Australian qualitative study using a focus group methodology explored the current 
needs and concerns of 10 women who recently completed treatment for breast cancer (Oxlad, 
Wade, Hallsworth & Koczwara, 2008).  One of the themes revealed in the study was fear of 
breast cancer recurrence immediately following primary treatment completion.  This concern 
consisted of specific thoughts about whether the treatment they were receiving was keeping the 
cancer away, if the cancer would return, how long they would have to live and what would 
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happen when the treatment (primary and secondary) stopped causing fears about recurrence 
(Oxlad et al., 2008). 
In a descriptive exploratory study using telephone interviews with a convenience sample 
of 200 breast cancer patients from Illinois found that 39% of the patients reported fear of breast 
cancer recurrence, including concerns that the cancer had traveled to other parts of the body, 
concerns about the success of their surgery and that the cancer might return (Stephens et al., 
2008). In general, Stephens et al. (2008) found that fear of recurrence was a real threat for 
patient’s receiving any breast cancer surgery leaving concerns about the success of the surgery 
and the fear of recurrence 1-week post-operative for breast cancer surgery (Stephens et al., 
2008).  
A cross sectional, descriptive study of 109 women post-treatment for breast cancer in the 
southeastern United States participated in examining the variables associated with illness 
uncertainty and emotional distress in survivorship (Mast, 1998).  Several main findings were 
identified, first age was inversely related to fear of cancer recurrence (older women were less 
likely fear cancer uncertainty than younger women) (p<0.01) and women with four or more 
years of college had lower illness uncertainty than women with less than two years of college 
(p=0.008) (Mast, 1998).  Secondly, symptom distress (those symptoms residual from cancer 
treatment or new unknown symptoms) and fear of cancer recurrence contributed to greater 
emotional distress (p= 0.003) (Mast, 1998).  
In summary, the younger breast cancer survivors tend to experience greater levels of fear 
of cancer recurrence than their older survivors (Connell et al., 2006; Crane-Okada et al., 2012; 
Janz et al., 2011; King et al., 2000; Kornblith et al., 2007; Mast, 1998; McGinty et al., 2010; 
Thewes et al., 2012; Waljee et al., 2008).  In several studies women who were less educated 
 
 
20 
reported greater FOR than those with some college education (Janz et al., 2011; King et al., 
2000; Mast, 1998) and one study found that low acculturated Latinas experienced increased FOR 
than African American survivors (Janz et al., 2011).  In some of the studies increased fear of 
cancer recurrence was associated with the increased stage of the cancer at diagnosis (McGinty et 
al., 2010; Waljee et al., 2008).  Treatment concerns were associated with FOR regarding type of 
treatment, esthetics of breasts after treatment and effectiveness of treatment.  FOR was increased 
in those patients who had lumpectomy compared to mastectomy patients (Connell et al., 2006; 
Janz et al., 2011), more breast asymmetry post treatment (Waljee et al., 2008) and worries about 
the treatment being effective enough to keep the cancer away (Oxlad et al., 2008; Stephens et al., 
2008).  
Pain, Fatigue, Sleep Disturbances and Fear of Breast Cancer Recurrence.  
Modifiable state factors associated with fear of breast cancer recurrence include physiological 
symptoms such as pain, fatigue and sleep disturbances and psychological factors including 
depression, perceived stress and anxiety.  
A qualitative study in 2007 studying 20 breast cancer survivors in the northeastern United 
States their physical, psychological needs and associated information and support needs during 
survivorship (Cappiello, Cunningham, Knobf, & Erdos, 2007). The results found that the women 
in this sample reported fatigue as the greatest physical complaint across all three-time periods (3, 
6 and 12 months) and that the fatigue “never stopped” even after treatment (Cappiello et al., 
2007, p. 283).  Sleep difficulties were also ranked high among the physical symptoms, frequently 
citing fear of cancer recurrence as a cause for sleep disturbances (Cappiello et al., 2007). The 
main psychological complaint was fear of recurrence that persisted through the first year post-
treatment causing increased anxiety (Cappiello et al., 2007). Overall, anxiety was also a common 
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concern during the first year, however changes in mood and sadness dissipated over time 
(Cappiello et al., 2007). Women reported that one of their greatest challenges was “trying to get 
back to normal” after treatment for breast cancer and that they could have benefited from more 
information during the transition (Cappiello et al., 2007, p. 287). These findings indicate the 
need for further information and support for women acclimating from treatment to routine living 
during the first year post breast cancer treatment (Cappiello et al., 2007). 
A descriptive analysis of 203 Caucasian and African American breast cancer survivors 5-
9 years post-treatment were studied to assess the influence of symptoms, uncertainty and 
communication with providers on well-being (Clayton, Mishel, & Belyea, 2006).  Results 
yielded that symptom bother (pain, fatigue and other symptoms) accounting for 11% of the 
variance related to thoughts of cancer recurrence (Clayton et al., 2006).  Age was found to be 
directly associated with symptom bother (as age increased symptom bother decreased) and 
indirectly associated with feelings of decreased uncertainty, better mood and lower worry of 
recurrence  (Clayton et al., 2006).    
A study of 572 breast cancer survivors in the Western United States investigated patterns 
of sleep duration change across the breast cancer survivorship period including demographic and 
clinical predictors and cancer-related symptoms (Alfano et al., 2011).  Findings revealed that half 
of the survivors did not report sleep changes over time however 25% reported sleep changes that 
were temporary, late-occurring or a sustained change (Alfano et al., 2011).  Those survivors with 
the sustained or temporary change were more likely to have been treated with chemotherapy 
(p<0.001) or experienced weight gain post diagnosis (p=0.04) (Alfano et al., 2011).  The group 
who experienced sustained sleep change reported greater fatigue related concerns (severity, 
affective, and sensory) (p<0.0001) compared to the no change group (Alfano et al., 2011).  There 
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were no significant findings between the sleep groups with regard to fatigue, fear of recurrence 
or perceived stress (Alfano et al., 2011).  Their findings suggest that survivors treated with 
chemotherapy and those with weight gain post breast cancer diagnosis may be at greater risk for 
sleep pattern changes hence greater risk for fatigue implicating the need for sleep screening and 
intervention as part of routine cancer survivorship assessment (Alfano et al., 2011).   
Triggers of uncertainty regarding breast cancer recurrence were studied in 244 Caucasian 
and African-American women 5 to 9 years post-breast cancer diagnosis (Gil et al., 2004).  The 
women in this study reported an average of 2 triggers of uncertainty per month consisting of 
hearing about someone else having cancer, doctor’s appointments, and cancer information in the 
media (news, TV) (Gil et al., 2004).  Other triggers included new aches, pains or other physical 
symptoms, and sights, sounds and smells that reminded them of their breast cancer experience; 
although their fear of recurrence was not constant the triggers remained persistent over time (Gil 
et al., 2004). The most common trigger for African-American women was new symptoms and 
for Caucasian women hearing about someone else with cancer (Gil et al., 2004).  Older women 
reported significantly fewer triggers (r = -0.16, p<0.01) and women with higher education 
reported more triggers (r=0.21, p<0.001) (Gil et al., 2004).  Caucasian women were more likely 
to report their fear of recurrence being triggered by hearing about someone else’s cancer, 
environmental factors and information in the media regarding cancer than African-American 
women (Gil et al., 2004).   
An exploratory qualitative analysis of 276 email messages from 60 breast and prostate 
cancer patients in Norway examined the content of emails sent to oncology nurses (Grimsbo, 
Finset, & Ruland, 2011).  Themes from the 38 breast cancer patients revealed that women 
expressed fear and anxiety related to relapse or metastases. Their fear was related to physical 
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changes in their bodies (new experience of pain in their breasts or armpits and tiredness) 
(Grimsbo et al., 2011). Expressing concerns about every little change in the body, topics they 
read about in the paper related to cancer and knowing about patients that receive other types of 
treatment (Grimsbo et al., 2011).  A final trigger that was identified was related to topics that 
patients read about in the newspaper and in their peer-to-peer on-line communication involving 
the type of cancer treatment they received in comparison to their peers raising concerns about 
their choices and effectiveness of the treatment they received (Grimsbo et al., 2011). 
A cross-sectional study in Italy examined quality of life, fatigue and depression in 255 
long-term breast cancer survivors (Romita, Cormio, Giotta, Colucci & Mattioli, 2012).  The 
mean survival time was 10.5 years (range 5 to 32 years), education level was low with less than 8 
years of school, most had received combined therapy (surgery, radiation and chemotherapy), the 
majority did not smoke and also did not exercise  (Romita et al., 2012). Sleep patterns in this 
sample reported regular sleep (50%) and 46% reported disturbed sleep (Romita et al., 2012). 
Survivors with lower education (p=0.007) and two or more comorbidities experienced greater 
fatigue, fatigued survivors were significantly more depressed (p=0.000) and reported more 
disrupted sleep (p=0.000) overall fatigue was found to be moderate and severe (34%) and mild 
(66%) (Romita et al., 2012).  These findings were similar with depression, survivors with 
depression (37% depressed, 20% moderate to severe depression) were found to have higher 
fatigue (p=0.000) and more disturbed sleep (p=0.000) (Romita et al., 2012). 
A study of 47 breast cancer survivors within 1 to 14 months post treatment found that the 
majority of the women experienced persistent and troubling fears about disease recurrence 
(Allen, Savadatti, & Levy, 2009).  These fears were often triggered by physical symptoms of 
unknown origin, and that sometimes they described their distress or depression as being related 
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to fear of recurrence (Allen et al., 2009).  Fear of recurrence was common and persistent, 
although women transitioning out of treatment who exhibited fear and distress were also 
identified as very resilient (Allen et al., 2009).  With these findings the researchers recommend 
that there are implications for nursing and other healthcare providers to consider the transition 
period post treatment as “window of opportunity” to support women’s coping mechanisms and 
strategies to promote health and well-being (Allen et al., 2009, p.76). 
 A qualitative study of semi-structured interviews with sixteen women post- breast cancer 
treatment examined the nature of thoughts and feelings regarding the possibility of breast cancer 
recurrence (Vickberg, 2001).  Findings revealed that five of the sixteen women experienced 
strong feelings of recurrence whereas five other women expressed little or no fear of recurrence 
one citing that she felt blessed and confident that the cancer was not going to come back 
(Vickberg, 2001).   In addition, triggers associated with fear of recurrence were examined with 
being around others with cancer or hearing about cancer being the most common trigger of fear 
of recurrence (Vickberg, 2001).   Doctor appointments and testing such as mammograms and 
future oriented activities also created anxiety associated with fears of recurrence (Vickberg, 
2001).  Three of the women expressed that fear of recurrence was triggered by physical 
symptoms from the initial breast cancer (Vickberg, 2001).  
 In summary, physical symptoms such as pain, fatigue, anxiety and symptoms related to 
the cancer treatment were found to be associated with increased FOR (Allen et al., 2009; Clayton 
et al., 2006; Gil et al., 2004; Grimsbo et al., 2011; Vickberg, 2001). Older women reported 
reduced symptom bother or triggers and lower worry of cancer recurrence (Clayton et al., 2006; 
Gil et al., 2004).  Those women with less education reported greater fatigue and fatigued 
survivors were more depressed and had more disturbed sleep (Romita et al., 2012) and FOR was 
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reported as the cause for sleep disturbances in some women and was cited to be their main 
psychological complaint that persisted throughout the first year post treatment creating increased 
anxiety (Cappiello et al., 2007). 
Depression, Perceived Stress and Anxiety and Fear of Breast Cancer Recurrence.  
Depression, perceived stress and anxiety and their association with fear of breast cancer 
recurrence has become a greater concern in the study of breast cancer survivorship in terms of 
improving quality of life through early screening and intervention.  A study of 89 women 
examined depression, anxiety and cancer related distress post-treatment for breast cancer 
(Costanzo et al, 2007).  They found depression, anxiety and cancer related distress to be true for 
younger women and those women of any age with some history of college education 
demonstrated greater distress (Costanzo et al, 2007). Women demonstrated elevated depression 
with a self-reported history of anxiety, depression or emotional disturbance and also those taking 
antidepressants were at greater risk for depressive symptoms (Costanzo et al, 2007).  Women 
who received more extensive treatment had greater cancer-related anxiety but not depressive 
symptoms and those women who received chemotherapy had a greater recurrence worry than 
those who only received radiation (Costanzo et al, 2007). Stage of cancer was not found to be 
significant (Costanzo et al, 2007). 
Factors contributing to adaptive survivorship were examined in a longitudinal study of 70 
women with Stage I and II breast cancer in the Midwest, United States (Stanton et al., 2002).  
Using the Fear of Recurrence Scale by Northouse the researchers found that older women 
reported less fear of recurrence at 3-months (r=-0.39, p<0.001 and 1-year (r = -0.52, p<0.001) 
(Stanton et al., 2002).  Avoidance-oriented coping at study entry was related to lower Profile of 
Mood States Distress at 3-months but increased fear of recurrence at 1 year (Stanton et al., 
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2002).  At 1 year, older women reported less fear of recurrence (partial r = -0.29, p < 0.05) 
(Stanton et al., 2002).  Women who scored high in hope were predicted to have lower fear of 
cancer recurrence 3-months later if they coped through positive reinterpretation at diagnosis 
(p<0.05) (Stanton et al., 2002). Coping through avoidance at diagnosis predicted decreased fear 
of recurrence distress at 3-months but higher fear of recurrence at 1-year for 70 women with 
stage I and II breast cancer through their first year of treatment; this finding suggests that 
avoidance is an important risk factor for cancer specific maladjustment (Stanton et al., 2002). 
Post-menopausal women (N=153) in New Zealand with early stage breast cancer 
participated in a cross-sectional study design to examine the relationship between fear of 
recurrence and illness perceptions, medication beliefs, treatment side effects, demographic 
factors and emotional distress (Corter, Findlay, Broom, Porter & Petrie, 2013).   Using the Worry 
About Cancer scale to measure fear of recurrence a significant difference was seen in fear of 
recurrence between unemployed women (M=15.1, SD = 8.6) and employed women (M=12.9, 
SD=6.2) (p=.03) with unemployed women experiencing greater fear of recurrence (Corter et al., 
2013). No differences were noted between younger and older women (p=.12), in a relationship or 
not in a relationship (p=.95), ethnicity (p=.27) or time since diagnosis (p=.07) (Corter et al., 
2013). There were no noted differences between women who received chemotherapy and those 
that did not and those that had radiation and those that did not (Corter et al., 2013).  There was 
significant relationship between mean anxiety and depression scores and fear of recurrence (p 
=0.001) (Corter et al., 2013). Higher fear of recurrence was associated with more symptoms 
related to breast cancer (p=0.001) and those that believed that their cancer was caused by stress 
experienced significantly higher fear of recurrence (p=.05) than women who did not know what 
caused their cancer (p= .01), lifestyle, hormones, genetics and chance were not significantly 
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related to fear of cancer recurrence (Corter et al., 2013).  In the regression model, fear of 
recurrence was significantly associated with negative emotions including lower beliefs about 
treatment control (p=0.001), greater timelines of experiencing breast cancer (p=0.002) and more 
symptoms associated with breast cancer (p<0.05) (Corter et al., 2013).  Illness perceptions, 
beliefs about medicines, number and severity of reported side effects from aromatase inhibitors, 
anxiety, depression and employment status comprise about 61% of the variance in fear of 
recurrence scores (Corter et al., 2013).  
A study of 307 women in the Netherlands with early stage breast cancer (n=117) or 
benign breast problems (n=190) looking at social, psychological, support factors and predictors 
of fatigue at 6 and 12 months post-surgical treatment (De Vries, Van der Steeg & Roukema, 
2009).  In the breast cancer group predictors of fatigue were depressive symptoms, poor social 
support and neuroticism (De Vries et al., 2009).  In the breast cancer group, none of the 
demographic or clinical factors predicted fatigue at Time 2 and 3 (De Vries et al., 2009). Trait 
anxiety (p < 0.001) and extraversion (p < 0.05) at Time 2 and trait anxiety (p<0.05), extraversion 
(p<0.05), and depressive symptoms (p<0.05) at Time 3 predicted fatigue in the breast cancer 
group (De Vries et al., 2009).  These findings suggest that those individuals that are fatigued 
early in their diagnosis many will continue to experience fatigue later on in their treatment and 
post-treatment therefore suggesting early fatigue screening and intervention (De Vries et al., 
2009). 
In a study of 331 ethnically diverse women in California within 3 to 7 months of 
diagnosis were examined for depressive symptoms (Wong-Kim & Bloom, 2005).  Younger 
women with higher levels of pain (p = 0.035), lower levels of self-esteem (p < 0.0005) and lower 
emotional support (p < 0.0005) were at greatest risk for depressive symptoms (Wong-Kim & 
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Bloom, 2005).   However women of any age with severe treatment side effects, low self-esteem 
and low emotional support were also at risk (Wong-Kim & Bloom, 2005).  Only amount of pain 
predicted depressive symptoms; conversely disease severity, type of surgery, number of positive 
lymph nodes, nausea were not significant for predicting depressive symptoms (Wong-Kim & 
Bloom, 2005).  
A prospective quality of life study of 506 women diagnosed with ductal carcinoma in situ 
(DCIS) or early invasive breast cancer (EIBC) stage I – IIA was performed using interviews at 4-
6 weeks, 6 months and 2 years post-treatment (Liu et al., 2011).  Moderate fear of recurrence 
was reported in 24.8% of patients and 4% of the women reported high levels of fear of 
recurrence (Liu et al., 2011).  Using three stepwise multivariable linear regression models Liu et 
al., (2011) found that younger age, EIBC stage IIA breast cancer, lower social support and 
elevated anxiety was associated with higher fear of cancer recurrence (measured with 4-items 
from the Concerns About Recurrence Scale (CARS) (P < 0.05; final models R² = 0.25-0.32).  
DCIS patients had lower FOR than stage IIA patients (P < 0.01) (Liu et al., 2011). Breast cancer 
survivors with higher levels of education (> high school) reported less FOR at baseline and 
greater depressive symptoms at baseline had higher fear of cancer recurrence; neither of these 
symptoms were observed at 6-months or 2-years (Liu et al., 2011).   
A study of 1,957 breast cancer survivors in California examined the occurrence of fatigue 
and associated demographic, medical and psychological factors compared to the general 
population (Bower et al., 2000). Women who were who were fatigued were younger (p < 0.05), 
earned lower annual income (p < 0.05) and less likely to be in a significant relationship (p < 
0.05) (Bower et al., 2000).  Women in the fatigue group also experienced more physical 
complaints such as arthritis (p < 0.05), headaches (p < 0.05) and heart disease (p < 0.05) (Bower 
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et al., 2000).  The women in the fatigue group were also more likely to have been treated with 
chemotherapy or chemotherapy and radiation than their non-fatigued counterparts (Bower et al., 
2000).  Women with fatigue reported greater sleep disturbances, more severe and disabling pain 
and higher level of depressive symptoms (Bower et al., 2000).  The greatest predictors of fatigue 
were depression (p = 0.0001) and pain (p = 0.0001) (Bower et al., 2000).  Although fatigue was 
not a significant concern for the women in this study, those women that did experience fatigue 
were more likely to experience depression, bodily pain and sleep disturbances (Bower et al., 
2000). 
A study of 169 women (81 with breast cancer and 88 benign breast problems) in The 
Netherlands found that trait anxiety assessed before diagnosis was the only significant predictor 
of depressive symptoms (r = .59, p < 0.001 before diagnosis and r = .66, p < 0.05 at 1-month) 
and fatigue (r = .66, p < 0.001 before diagnosis and r = .60, p < 0.001 at 1-month) (De Vries, 
Van der Steeg, & Roukema, 2009).  Age, marital status, having children and having paid work 
were unrelated to trait anxiety, depressive symptoms or fatigue (DeVries et al., 2009). Patients 
with benign and breast cancer with high trait anxiety also scored high on fatigue (DeVries et al., 
2009).  The results identified that by incorporating all four time points (pre-diagnosis, 1-month, 
3-months, 6-months) among both groups (benign and breast cancer) that patients who scored 
high on trait anxiety appeared to be at risk for developing depressive symptoms and fatigue 
(DeVries et al., 2009).  The researchers recommend that women with a suspicion of breast cancer 
should be screened for trait anxiety and for those individuals who score high in trait anxiety 
psychological therapy should be offered as part of their treatment plan (DeVries et al., 2009). 
A study in Scotland examined the prevalence of severe fatigue and associations with 
activity level and psychological distress in 69 breast cancer survivors at least 6-months post-
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treatment (Young & White, 2006).  Those patients that experienced cancer related fatigue also 
reported greater symptoms of anxiety, depression and psychological distress (p<0.001) (Young 
& White, 2006).  Fatigue increased as the number of treatment modalities increased for those 
survivors with fatigue (p<0.05) (Young & White, 2006).  Correlations were significant between 
fatigue and beliefs about activity, psychological distress, and fear of recurrence (p<0.01).  Fear 
of recurrence was found to be a significant predictor of fatigue but was mediated by 
psychological distress and beliefs about activity and therefore fear of recurrence had an indirect 
association with fatigue (p< 0.01) (Young & White, 2006). 
A recent cross-sectional study of 1,128 long-term breast cancer survivors in two 
Midwestern university cancer centers explored the effect of age at diagnosis on fear of breast 
cancer recurrence and predictors of fear of recurrence (Ziner et al., 2012).  Younger women were 
defined as ages 45 years and younger and older age was considered 55 to 70 years of age (the 
age gap from 46 – 54 years was deliberate as part of the study design) (Ziner et al., 2012). 
Findings were based the 505 younger women and 623 older women who participated in the 
study.  Consistent with the literature the younger women experienced greater fear of recurrence 
than the older women in the study (t = 7.7 – 15.4, p < 0.001) (Ziner et al., 2012).  Age (p = 
0.001), perceived risk of recurrence (p = 0.001, trait anxiety (p = 0.001) and breast cancer 
reminders (p = 0.001) were all associated with fear of recurrence (Ziner et al., 2012).  Although 
age at diagnosis was not associated with breast cancer survivor self-efficacy (ability to manage 
symptoms, emotions and facilitate support related to breast cancer) breast cancer survivor self-
efficacy was inversely related to higher perceived risk of recurrence (p = 0.07), symptom bother 
(p< 0.001), and trait anxiety (p < 0.001) (Ziner et al., 2012).  Breast cancer survivor self-efficacy 
predicted lower fear of cancer recurrence (r = -0.183, p < 0.001) and demonstrated a partial 
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mediation effect (p = 0.05) on the relationship between the antecedent variables age at diagnosis, 
perceived risk of recurrence, trait anxiety and breast cancer reminders and outcome variable fear 
of recurrence (Ziner et al., 2012). 
Understanding more about fear of recurrence and how the demographic, psychological 
and physiologic factors influence fear of recurrence will shape the future interventions become 
more individualized and targeted.  The shift from breast cancer diagnosis and treatment to 
quality of life and well-being related to the psychological needs during survivorship has brought 
fear of breast cancer recurrence to the forefront as a priority for further investigation. 
In summary, psychological symptoms associated with FOR were found to be 
bidirectional in their relationships and associated with other demographic factors. Anxiety was 
found in some of the studies to be associated with increased FOR (Corter et al., 2013; Liu et al., 
2011; Ziner et al., 2012) and depression (Corter et al., 2013).  Trait anxiety predicted fatigue 
(DeVries et al., 2009) and depressive symptoms (DeVries et al., 2009). Younger women with 
higher levels of pain, women of any age with severe treatment side effects and both younger and 
older women with low self-esteem and low social support were at greater risk for depressive 
symptoms (Wong-Kim & Bloom, 2005).  Younger age, lower social support, increased anxiety 
and greater depressive symptoms at baseline was associated with increased FOR however 
women with higher education reported less FOR at baseline (Liu et al., 2011).  Increased cancer 
related fatigue was associated with greater anxiety, depression, psychological distress and fear of 
recurrence (Young & White, 2006). 
Fear of Recurrence and Breast Cancer Survivors.  The National Cancer Institute 
(2013) defines cancer recurrence as a cancer that returns where it started or in another place in 
the body after treatment and after a period of time that the cancer could not be detected.  The 
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literature tends to use worry and uncertainty synonymously with fear in fear of recurrence 
(Simard & Savard, 2009; Vickberg, 2003) and hence the development of various fear of 
recurrence instruments. In a 2009 study validating a fear of recurrence inventory, the author 
argued that one of the challenges with researching fear of cancer recurrence was the lack of 
consensus for an accepted definition for fear of recurrence (Simard & Savard, 2009).  Despite 
some of these differences fear of cancer recurrence has become a legitimate concern related to 
breast cancer survivorship. 
 The Concerns About Recurrence Scale (CARS), an instrument developed by Vickberg 
(2003), was designed to assess the overall fear and the extent and nature of women’s fears about 
the possibility of breast cancer recurrence.  The instrument was assessed in 169 breast cancer 
survivors from five physician practices at a large New York City medical center. Participants 
needed to be 18-years of age or older, speak English, within 7 years of diagnosis of local or 
regional breast cancer and have received surgery for breast cancer and post-treatment (Vickberg, 
2003).  The CARS defines fear of recurrence as “the breast cancer coming back in the same 
breast or other areas of the body or a new breast cancer on either breast” (Vickberg, 2003, p. 18).  
The CARS contains two parts: 1) the overall fear of recurrence and 2) the nature of women’s 
fears of recurrence (Vickberg, 2003). 
Using exploratory factor analysis conducted to determine the structure of the CARS and 
to identify meaningful subsets of items the results yielded a four-factor solution that accounted 
for 70% of the variance (Vickberg, 2003).  The overall fear index was found to have a high 
internal consistency (α =.87) and significantly correlated with all four CARS subscales: Death (r 
= .64); Health (r = .64); Roles, (r= .50), and Womanhood (r = .53) (all correlations p < .0001) 
(Vickberg, 2003).  Approximately 45% of the women reported moderate levels of fear of 
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recurrence and 10% high levels of fear; for some of the women recurrence was the biggest fear, 
aware that disease could recur at any time and others revealed that the fears were subtle yet 
constant in addition to some revealing that fear of recurrence interfered with their ability to plan 
for the future (Vickberg, 2003).  Finally, the background variable of age was the only significant 
variable found to be negatively related to overall fear (p < .05) (Vickberg, 2003). Vickberg 
(2003) found that stage of cancer, mastectomy and time since diagnosis were not a predictor of 
FOR. 
A study of 72-breast cancer survivors was studied for severity of four common concerns 
(fear of the future, physical limitations, pain, problems with family or friends) at 3, 7, 11, 15 
months and 6 years after diagnosis (Lebel et al., 2007).  They found that fear of the future (fear 
of recurrence) was the most stressful concern for breast cancer survivors (Lebel et al., 2007).  
They noted that although the perceived stressfulness of fear of the future appeared to decline 
during the 3 and 7-month period after diagnosis, it stabilized at a constant state through 6 years 
(Lebel et al., 2007). 
A prospective Dutch study of 136 breast cancer survivors designed to evaluate the 
psychometric properties of the Dutch version of the Concerns About Recurrence Scale (CARS) 
and to measure the concerns about disease recurrence and how fear of recurrence effects quality 
of life (Van den Beuken-van Everdingen et al., 2008).  Moderate to high levels of fear were 
reported by 56% of women with pain found to be a strong predictor of fear of recurrence 
(p<0.001), overall fear decreased with age (p < 0.012) (Van den Beuken-van Everdingen et al., 
2008). Women with higher education levels had significantly more health and role worries (on 
the CARS subscales) than women with lower education (Van den Beuken-van Everdingen et al., 
2008). 
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In a German study or 1083 breast cancer survivors character and frequency of fear of 
cancer progression was studied with the relationship with cancer-related intrusive cognitions 
(Menhert, Berg, Henrich & Herschbach, 2009).  Findings revealed significant correlations 
between fear of cancer progression and intrusive thoughts (r=0.63), avoidance (r= 0.57), 
hyperarousal (r=0.54) and posttraumatic stress disorder diagnosis (r=0.42) (Menhert et al., 2009).  
Intrusive thoughts and being afraid of disease progression demonstrated the highest relationship 
along with having physical symptoms of anxiety such as rapid heart rate, being afraid of severe 
medical treatments and being nervous prior to doctor’s appointments (Menhert et al., 2009). 
An exploratory study describing the extent and nature of fear of cancer recurrence in 
relation to socio-demographic characteristics, treatment related characteristics, psychological 
distress and quality of life in 51 African-American breast cancer survivors in Washington D.C. 
was performed (Taylor et al., 2011).  Sixty-seven percent of the women reported some degree of 
fear of recurrence and low to moderate levels of fear of recurrence (M=2.65, SD=1.44) using the 
Concerns About Recurrence Scale (CARS) (Taylor et al., 2011).  Overall fear was negatively 
associated with time since diagnosis (r =-.35, p < .05) and negatively related to quality of life 
(r=-.38, p>.01) (Taylor et al., 2011).  In addition, overall fear of recurrence was positively related 
to global psychological distress (r = .43, p < .01), younger patients experienced higher levels of 
fear of cancer recurrence and there was no difference between fear of cancer recurrence worries 
and surgery type (Taylor et al., 2011). 
A qualitative study of 21 breast cancer survivors at least 3-months post-treatment in 
California exploring the different quality of life experiences and needs (Ferrell, Grant, Funk, 
Otis-Green & Garcia, 1997).  Some of the common shared experiences expressed by the women 
related to physical well-being were pain, fatigue, insomnia and that their complaints were not 
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always taken seriously by their health care team (Ferrell et al., 1997).  Fear of recurrence was a 
common shared experience for the women, and although it may dissipate for periods of time 
throughout survivorship physical reminders of the cancer or hearing about cancer would recreate 
fears of recurrence; one women stating “I guess it just never goes away” (Ferrell et al., 1997, 
p.20).  This early study provided a foundation for further exploration, support, management and 
intervention of quality of life issues in breast cancer survivorship. 
A study of 89 breast cancer patients from 5-Midwest treatment centers examined the 
psychological adjustment during the 3-months following treatment for breast cancer and health 
related quality of life (Costanzo et al., 2007).  Many of these women experienced moderate 
cancer related anxiety and concerns about ongoing physical symptoms and fear of cancer 
recurrence using the Concerns About Recurrence Scale (CARS) (Costanzo et al., 2007). Level of 
education (mainly some college but less than those who completed college or a graduate degree) 
predicted greater FOR distress (p < 0.001) (Costanzo et al., 2007).   Aside from side effects and 
physical problems, fear of recurrence was the greatest source of distress during the post 
treatment period (Costanzo et al., 2007).  Women who reported extensive treatment therapy 
(mastectomy) were found to be a greater predictor of fear of recurrence distress than women who 
received lumpectomy (p =0.012) at 3-months in 71 breast cancer survivors (Costanzo et al., 
2007). 
A study examining factors associated with quality of life in a sample of 246 randomly 
selected cancer survivors and their family members was performed to identify factors associated 
with fear of recurrence of cancer survivors and their caregivers and to determine if survivors and 
family caregivers influenced each other’s fears of recurrence (Mellon, Kershaw, Northouse, & 
Freeman-Gibb, 2007).  Study findings identified that fear of recurrence was predominately 
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determined by the individual not by their partner and that each person’s perception had more 
influence on their individual level of fear of recurrence then the influence on their partner 
(Mellon et al., 2007).  One partner effect finding was that older survivors with younger 
caregivers and older caregivers with younger partners both experienced increased fear of cancer 
recurrence (p < 0.01) and caregivers who were family members also experienced greater fear of 
recurrence (p < 0.001) (Mellon et al., 2007).  Families that reported concurrent family stressors 
had more fear of recurrence and the lower quality of life (p < 0.01) (Mellon et al., 2007). 
Survivors and caregivers who had more positive meaning with the illness experienced 
significantly less fear of recurrence (p < 0.01) (Mellon et al., 2007). 
A study of 231 cancer survivors, including breast cancer survivors (n = 94), found fear of 
recurrence to be a predictor for increased outpatient visits (r = .16, p = .025), emergency room 
visits (r = .16, p = .028) and quantity of medications used (r = .20, p = .013) (Lebel, Tomei, 
Feldstain, Beattie, & McCallum, 2013).  In particular, both younger and female survivors 
reported greater fear of recurrence, more visits to health care professionals and medication 
utilization (female survivors only) (Lebel et al., 2013). Overall results suggest that younger, 
female cancer survivors reported greater fear of cancer recurrence and greater health care 
utilization (Lebel et al., 2013).   
A randomized controlled trial of 84 breast cancer survivors from Tampa, Florida 
examined the effects of a 6-week Mindfulness Based Stress Reduction (MBSR) program as an 
intervention for psychological stressors (perceived stress, anxiety, depression, fear of recurrence) 
and physical symptoms (pain, fatigue, sleep disturbances) in early breast cancer survivorship 
(Lengacher et al., 2009).  This is the first intervention study using MBSR as an intervention for 
reducing fear of breast cancer recurrence (Lengacher et al., 2009).  Subjects in the MBSR 
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intervention group demonstrated lower scores at 6-weeks compared to the usual care group in 
fear of recurrence (p = 0.007), fear of recurrence problems (p = 0.01), state anxiety (p =0.03), 
trait anxiety (p = 0.004) and depression (p = 0.03) (Lengacher et al., 2009). 
Another intervention study of 19 women post breast cancer treatment from Tampa, 
Florida assessed the impact of an 8-week MBSR program as an intervention for fear of 
recurrence, perceived stress, anxiety, and depression and physical symptoms (Lengacher et al., 
2011).  This study was designed to assess the feasibility of an 8-week MBSR program on 
psychological, physical symptoms and quality of life in early breast cancer survivorship.  The 
intervention of the 8-week MBSR program demonstrated a reduction in fear of recurrence (p = 
.01), fear of recurrence concerns (p = .04), state anxiety (p = .09), trait anxiety (p = .01), 
depression (p = .009) and perceived stress (p = .01) (Lengacher et al., 2011). 
In summary, FOR remains a predominate concern for women post treatment for breast 
cancer and into survivorship (Costanzo et al., 2007; Ferrell et al., 1997; Lebel et al., 2007; Van 
den Beuken-van Everdingen et al., 2008).  As discussed in the earlier studies, age, physical 
symptoms and anxiety were associated with fear of recurrence (Ferrell et al., 1997; Lebel et al., 
2013; Lengacher et al., 2009; Menhert et al., 2009; Taylor et al., 2011; Vickberg, 2003). In one 
study younger patients experienced greater FOR and more health care utilization (Lebel et al., 
2013) suggesting that there is a relationship between health-related anxiety and increased health 
care utilization and health care costs (Lebel et al., 2013; Barsky, Ettner, Horsky, & Bates, 2001). 
Other studies revealed that higher levels of education (Costanzo et al., 2007; Van den Beuken-
van Everdingen et al., 2008) and patients who received mastectomy (Costanzo et al., 2007) 
reported greater FOR contradicting findings from previous cited studies where these factors were 
associated with lower FOR.  
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Summary   
 It is evident in the empirical research reviewed that fear of breast cancer recurrence is a 
legitimate and consistent concern among breast cancer survivors in the short and long term.  
Younger age, limited education, increased fatigue, anxiety and depression are some of the more 
common themes seen in the research to be associated with fears of cancer recurrence. However, 
there tends to be preliminary findings that some of these factors may be influenced by age, 
race/ethnicity and psychological influences such as social support and coping skills.  Several 
studies demonstrated that increased psychological concerns, like fear of recurrence particularly 
in younger women resulted in more medical visits hence driving up the costs of health care.  It is 
clear from these findings and the qualitative requests from the women in these studies that there 
is substantial opportunity for early screening and intervention related to fear of recurrence and 
the associated factors.  
 
 
 
 
39 
 
 
Chapter Three 
Methods 
This chapter outlines the research methods and procedures used for this study.  The first 
section discusses the research design followed by the methods, setting, population and sample, 
recruitment, instrumentation and data analysis procedures.  
Design  
A cross-sectional research design was used to conduct a secondary data analysis among 
82 women who were post treatment for breast cancer. The original parent study was an R-21 
NCI funded (grant #R21CA109168), randomized controlled intervention trial examining the 
Effects of Mindfulness Based Stress Reduction in Early Stage Breast Cancer Recovery 
(Lengacher et al., 2009). The current study utilizes the baseline data from the R-21 study for a 
secondary data analysis examining the relationship between stable, non-modifiable trait factors 
and transient, modifiable state factors on fear of cancer recurrence in breast cancer survivors.  
See Figure 1 in the Theoretical Framework section. 
Setting and Subjects.  Study subjects were recruited from the H. Lee Moffitt Cancer 
Center and Research Institute at the University of South Florida in Tampa, Florida. The H. Lee 
Moffitt Cancer Center is a National Cancer Institute and a nationally recognized Cancer Center 
of Excellence for the diagnosis and treatment of breast cancer.  The center’s catchment area 
includes nearly 3 million people and serves the largest population of breast cancer patients in the 
greater metropolitan area of Tampa, Florida.  Recruitment for the parent study started March 1, 
2006; all data collection was completed July 23, 2007.  
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Inclusion/Exclusion Criteria.  This study sample consists of 82 women age 21 or older 
who were diagnosed with breast cancer Stage 0, I, II, III and had undergone surgery 
(lumpectomy), received adjuvant radiation and/or chemotherapy and were within 18 months post 
treatment.  Other inclusion criteria included the ability to read and speak English at an 8th grade 
level in order to respond to survey questions.  Exclusion criteria included subjects advanced 
stage breast cancer (Stage IV), history of prophylactic mastectomy prior to current breast cancer 
treatment, severe psychiatric diagnoses and recurrent treatment for prior breast cancer. 
Power Analysis. Prior to initiation of this study, the available sample size was reviewed 
with respect to the specific aims to estimate statistical power and ability to draw reliable 
inferences from the analysis. For specific aims 1 and 2, the primary analytical method used 
consisted of Pearson or Spearman correlation coefficients (depending on statistical properties of 
the continuous variables being evaluated), or analysis of variance (ANOVA) for comparisons of 
means between levels of categorical variables. In these analyses, fear of recurrence, an 
approximately normally distributed continuous variable was the dependent variable of interest. 
Potential predictors of interest consisted of non-modifiable trait factors and modifiable state 
factors that may be associated with fear of recurrence. 
In correlation analyses, a sample size of 82 subjects provided 80% power (2-sided type I 
error rate of 0.05) to detect a “modest” non-zero correlation coefficient of 0.303 or higher. For 
ANCOVA, the power estimation assumed that 2 variables are adjusted for in the model that 
collectively account for 10% of the variation (R2) in ratings of fear of recurrence. With a fixed 
sample size of 82 subjects and 2-sided type I error rate of 0.05, the study provided 80% power to 
detect an R2 value of 0.0786 attributed to one additional independent variable (e.g. a modifiable 
state factor). This corresponds to a modest correlation coefficient of 0.28 indicating that the 
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analysis was adequately powered to detect a modest effect size. Thus, the sample size of 82 
subjects provided sufficient power to reliably examine specific aims 1 and 2. 
For specific aim 3, statistical power was influenced by the correlation (unknown) 
between the independent variable of interest and mediating variable of interest. With a sample 
size of 82 subjects, assuming 2-sided type I error rate of 0.05 and a modest correlation of 0.30 
between the independent variable and mediating variable (with variance of 1), the study provided 
80% power to detect a standardized beta coefficient of 0.32 or higher. This corresponds to a 
partial R2 value of 0.10, again indicating adequate power for the analysis.  
Instrumentation 
 The following instruments were used to measure the antecedent, mediator and the 
primary outcome variable: 
Antecedent Variables 
Demographic data were obtained using the Demographic Data Form (Lengacher 
et al., 2009) to capture participant socio-economic demographic data for a description to 
be the study sample.  Data gathered included age, race/ethnicity, education, marital 
status, and employment status. 
Clinical History data were obtained using the Clinical History Form (Lengacher 
et al., 2009) to capture cancer stage at time of diagnosis, treatment type, history of 
hormone use, family history of breast cancer, social/behavioral history, including 
exercise habits, history of alcohol, and tobacco use. 
Mediator Variables 
Physiologic Symptom data  (Pain, Fatigue and Disturbed Sleep) were measured 
using the M.D. Anderson Symptom Inventory (Cleeland et al., 2000).  This is a self-
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administered questionnaire measuring current symptoms and severity of symptoms 
experienced by the patient. The scale consists of 13-symptom items rated on presence and 
severity and 6-symptom interference items that are rated on level of symptom 
interference with function. For the purposes of this study only the subscales in the first 
section of the instrument that measures symptoms in the last 24 hours will be used.  Each 
of the subscales consists of one item for each variable (pain, fatigue and disturbed sleep) 
rated on Likert-type scale from 0 (not present) to 10 (as bad as you can imagine) 
(Cleeland et al., 2000).  Construct validity has been evidenced by principal factor analysis 
using data from the initial outpatient sample (cross-validation sample) and demonstrated 
high correlations with independent indicators of general symptom severity factors and 
gastrointestinal factors. The internal reliability consistency ranges from 0.82 – 0.94 
(Cleeland et al., 2000).  
Depression was measured using the Center for Epidemiological Studies 
Depression Scale (CES-D) (Radloff, 1977).  This is a 20-item instrument that measures 
depressive symptoms.  Respondents rate on a 4-point scale the frequency of their 
depressive symptoms within the past week (Radloff, 1977).  Items are rated from (0) 
rarely or none of the time to (3) most or all of the time.  The scoring provides a total 
depression score with a range from 0 to 60 of experienced symptoms (0 = not at all to 1 
day a week for all 20 items ranging to 60 = 5 to 7 days a week) with the higher scores 
indicating greater depressive symptoms (Radloff, 1977). The CES-D has demonstrated 
concurrent validity by clinical and self-report criteria and construct validity (Radloff, 
1977).  The Cronbach alpha value for the CES-D is 0.92 for breast cancer subjects 
(Radloff, 1977).   
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Perceived Stress was measured using the Perceived Stress Scale (Cohen, 
Kamarck, & Mermelstein, 1983).  This is a 10-item Likert-type instrument that measures 
“how often in the past month one appraises life situations as stressful” (Cohen et al., 
1983).  Items are scored as (0) Never to (4) Very often. Construct and predictive validity 
has been established with the Perceived Stress Scale and the CES-D and life events 
scales.  The internal consistency and reliability for the Perceived Stress Scale ranged 
from 0.84 – 0.86 (Cohen et al., 1983). 
Trait and State Anxiety was measured using the State Trait Anxiety Inventory 
(Spielberger et al., 1983).  This instrument contains two 20-item Likert-type scales that 
measures both state anxiety (Y1-present experience of anxiety), and is scored as: Not at 
all, Somewhat, Moderately so, Very much so.  Trait anxiety (Y2-trait anxiety the 
potential of the individual to experience anxiety symptoms when confronted with a 
threatening situation), scored as: Not at all, Sometimes, Often, Almost always).  
Concurrent, convergent, divergent and construct validity was represented using 
contrasted groups, correlations of T-Anxiety scale with other measures of trait anxiety, 
correlations of the STAI scales with other measures of personality and adjustment and 
also academic aptitude and achievements and investigations of the effects of different 
amounts and types of stress on S-Anxiety scores (Spielberger et al., 1983).  The internal 
consistency reliability for the State Trait Anxiety Scale is 0.95 (Spielberger et al., 1983). 
Outcome Variable   
Fear of Recurrence was measured using the Concerns about Recurrence Scale 
(CARS) (Vickberg, 2003).  This is a 30-item Likert-type instrument that measures the 
extent and nature of women’s fears about the possibility of breast cancer recurrence.  
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Comprised of 2 subscales overall fear of recurrence and worries related to recurrence. 
The first section contains 4 items that assesses the overall fear of recurrence, with the 
scoring (1) “I don’t think about it at all” to (6) “I think about it all the time” (Vickberg, 
2003).  The second subscale has four subscales comprising 26-items that assesses “what 
it is” and extent to which they worry about each item regarding death worries, health 
worries, role worries, role worries and womanhood worries.  The overall fear index was 
found to have a high internal consistency (α =.87) and significantly correlated with all 
four CARS subscales: Death (r = .64); Health (r = .64); Roles, (r= .50), and Womanhood 
(r = .53) (all correlations p < .0001) (Vickberg, 2003). Scoring for the second section is 
on a 5-point scale ranging from (0) not at all to (4) extremely (Vickberg, 2003). 
Convergence validity was determined comparing CARS to the Intrusive Thoughts and 
Avoidance Subscales of the Impact Events Scales (IES) and the Distress and Well-Being 
subscales of the Mental Health Inventory (MHI) (Vickberg, 2003).  Internal consistency 
for Concerns about Recurrence Scale is 0.87 for breast cancer subjects (Vickberg, 2003). 
Procedures 
Approval.  Approval for this study was granted by the Institutional Review Board at the 
University of South Florida (See Appendices) as a modification to the original study, Effects of 
Mindfulness Based Stress Reduction in Early Stage Breast Cancer Recovery.  This research 
study analyzes de-identified data collected during 2006 and 2007 R-21 NCI study.   
Data Collection Procedures.  The current study is utilizing the secondary baseline data 
set from the R-21 (NCI Grant #R21CA109168) Effects of Mindfulness Based Stress Reduction 
in Early Stage Breast Cancer Recovery (Lengacher et al., 2009).  Several recruitment methods 
were used for the parent study including introduction of the study by healthcare practitioners at 
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the H. Lee Moffitt Cancer Center in addition to brochures and flyers distributed throughout the 
cancer center.  Patients who expressed interest in the study were asked to complete a HIPAA 
authorization form that indicated their willingness to be contacted by a member of the trained 
research team.  Interested subjects were provided with an orientation session within the 6 weeks 
to 6 months post treatment for breast cancer that is the transition period from conventional 
treatment to adaptation and return to routine daily life and activities.  During the orientation 
session study details were explained, informed consent was obtained, and patients were 
randomized into the different groups (as a note, in order to maximize enrollment subjects who 
were randomized to the control group were offered the opportunity to receive the intervention 
after a wait period).  All subjects provided written consent and subjects received nominal 
compensation for their time of $50 at the completion and end of the study participation.  
Data Management.  Statistical Product and Service Solutions (SPSS) Version 21.0 was 
utilized for all data entry, data management and analysis related to this study.  Data were de-
identified and stored in password protected files secured in the investigator’s office to maintain 
confidentiality. Results were reported using only de-identified data and without patient 
identifiers. 
Data Analysis.  Data analysis was performed using quantitative statistical procedures in 
SPSS Version 21.0.  The primary outcome variable fear of recurrence (CARS Overall Fear and 
CARS Nature of Worry) was analyzed three ways using Pearson’s correlations, ANOVA and 
mediation analysis. 
Aim #1 – univariate analysis was used to evaluate the relationship between the 
antecedent variable (non-modifiable trait factors) including demographic information, 
clinical history, social/behavioral history and outcome variable, fear of breast cancer 
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recurrence (CARS overall fear and CARS nature of worry).  The dependent variable of 
interest, fear of breast cancer recurrence, was measured on continuous scale and therefore 
initially the univariate association was examined by correlation coefficients for 
continuous covariates and analysis of variance for categorical variables. See Figure 2 and 
3. 
 
 
 
Figure 2.  Model for Aim #1 
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Figure 3.  Model for Aim #1 
 
 Aim #2 – univariate analysis was used to evaluate the relationship between mediator 
variable (modifiable state factors) such as anxiety, depression, perceived stress, pain, fatigue and 
sleep disturbances and the outcome variable, fear of recurrence (CARS overall fear and CARS 
nature of worry).  The dependent variable of interest, fear of breast cancer recurrence, was 
measured on continuous scale and therefore initially the univariate association is examined by 
correlation coefficients for continuous covariates.  
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 Exercise 
 History of smoking 
Alcohol use 
 
     Fear of Breast Cancer  
            Recurrence 
 
CARS Nature of Worry  
 
 
Top 2 strongest independent 
trait factors identified 
 
Note: Two factors chosen due to 
sample size.  
 
 
 Antecedent Variable     Outcome Variable 
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Figure 4. Model for Aim #2 
 
 
 
Figure 5. Model for Aim #2 
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Aim #3 - assesses state factors that may mediate the effect on the relationships between 
antecedent trait factors and the outcome variable fear of recurrence.  The conceptual framework 
(Figure 1) lists postulated mediating variables.  Briefly, mediating variables are those that may 
help to explain “how” state factors mediate (influence) the relationship between the antecedent 
variable, trait factors and the outcome variable, fear of recurrence. This analytic approach for 
conducting this type of analysis is depicted in the diagram below. See Figure 6 and 7.  
 In Figure 6 and 7, trait factors (X1) are assumed to have both a direct and indirect path to 
the outcome of fear of breast cancer recurrence. “c” is the direct path, and “a  to  b” is the 
indirect path, passing through the mediating variable X2 (state factors).  The statistical approach 
to assess mediating effects was first to identify the significant univariate relationships, such as 
trait factors (i.e. “X1”) that are associated with fear of breast cancer recurrence (i.e. “Y”).  The 
next step adds a potential mediator (state characteristics: “X2”) to the model a linear regression 
procedure using the Preacher and Hayes (2008) method of assessing the indirect effects in a 
simple mediation model with bootstrapping of 5,000 iterations to obtain unbiased estimates from 
the sample of 82, to the extent possible, of the indirect effects of the potential mediating 
variables.  
If the X2 to Y relationship is strong, yet the X1 to Y relationship is substantially 
attenuated, this is considered an indication that variable X2 is a mediator of the relationship X1 
to   Y (i.e. X1 to X2  to  Y).  There also exists the possibility that X1 and X2 are so strongly 
correlated that they cannot survive in the model together, but in this case, the significance levels 
of both X1 and X2 are attenuated when they are evaluated simultaneously. 
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Figure 6. Model for Aim #3 
 
 
 
Figure 7. Model for Aim #3 
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Chapter Four 
  Results 
 This chapter summarizes the study findings of factors associated with the fear of breast 
cancer recurrence (CARS overall fear and CARS nature of worry) and the mediating effects of 
the mediator variables (modifiable state factors) on the antecedent variables (trait factors).  The 
results are presented by each of the three research aims. 
Sample 
 The sample size of 82 women post-treatment for breast cancer participated in the study 
from the H. Lee Moffitt Cancer and Research Institute in Tampa, Florida from March 1, 2006 to 
July 23, 2007.  In the original R-21 study 200 women were pre-screened and approached for the 
study, 7 were ineligible, and 109 declined participation for a variety of reasons ranging from not 
interested, distance from home, transportation issues, family obligations and health issues.  Two 
of the participants were lost to follow up. This study used the baseline data for the secondary 
analysis from the R-21 NCI funded randomized control trial.  Eighty-two (N = 82) women 
completed all the baseline tests comprising the final sample for this study and data analysis. 
 Participants were recruited from the H. Lee Moffitt Cancer Center and all participants 
completed a demographic data form, clinical history form, Perceived Stress Scale (PSS), State 
Trait Anxiety Inventory (STAI), M.D. Anderson Symptom Inventory (MDASI), Center for 
Epidemiologic Studies Depression Scale (CES-D) and the Concerns About Recurrence Scale 
(CARS) (CARS overall fear and CARS nature of worry) at their baseline assessment.   
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 The demographic assessment of the participants consisted of the following:  age, 
race/ethnicity, education, marital status and employment status.  Tables 1 and 2 displays the 
demographic characteristics for age with a mean age of 57 years (M = 57.18 SD + 9.136); the 
majority of the subjects were greater than 55 years of age (59.7%) with the remaining subjects 
being younger than 55 years of age (40.2%).  Eighty seven percent (n=72) of the study 
participants were White (White Hispanic, Ashkenazi Jewish, White non-Hispanic & Native 
American) and 12.2% (n=10) were Black non-Hispanic. The majority of the women who 
participated in the study were married (68.3%, n=56) and the rest of the women were unmarried 
(31.7%, n=26) (divorced, never married or separated). Fifty eight percent (n=48) of the women 
were employed at the start of the study and 41.5% (n=34) were not employed. The majority of 
the women (67.1%) reported some level of higher education (n=55) including college, graduate 
school or professional school; 23.2% of the women (n=19) reported some college or associate 
degree completion, 20.7% (n=17) reported a college education, and 23.2% (n=19) graduate 
school or professional schooling.  The remaining subjects reported vocational education level 
and lower, vocation beyond high school (11%, n=9), high school (17.1%, n=14) and some high 
school (4.9%, n=4). 
 
Table 1 
Demographics Characteristics (Frequency, Percentage, Mean, Standard Deviation) (N=82) 
Demographics Frequency Percent Mean SD 
Age   57.18 9.136 
< 55 33 40.2%   
55-64 28 34.1%   
65-75 20 24.4%   
>75 1 1.2%   
Race and Ethnicity     
White non-Hispanic 59 72.0%   
White Hispanic 9 11.0%   
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Table 1 Continued 
 
  
  
Black non-Hispanic 10 12.2%   
Ashkenazi Jewish 2 2.4%   
White non-Hispanic & Native American 2 2.4%   
 
 
Table 2 
Demographics Characteristics (Frequency, Percentage, Mean) (N=82) 
Demographics Frequency Percent 
Marital Status   
Married 56 68.3% 
Not married 26 31.7% 
Employment   
Employed 48 58.5% 
Unemployed 34 41.5% 
Education   
Some High School 4 4.9% 
High School graduate 14 17.1% 
Vocation Beyond High School 9 11.0% 
Some College or Associates Degree 19 23.2% 
 College 17 20.7% 
 Graduate School or Professional school 19 23.2% 
 
Clinical history data were collected for each of the study participants at baseline 
including stage of cancer at diagnosis, treatment history, history of hormone use, history of trait 
anxiety and family history of breast cancer; Table 3 represents the frequency and percentage for 
the study participant’s stage of cancer at diagnosis. The majority of the women were diagnosed 
with early stages of cancer, Stage 0 (17.1%, n=14) and Stage I (52.4%, n=43) the remaining 
women were diagnosed with Stage II (23.2%, n=19) and Stage III (7.3%, n=6).  Of the 82 
participants, 49 women (59.8%) received radiation only and 33 women (40.2%) received 
radiation and chemotherapy. Eighty women responded to the question regarding history of 
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hormone use.  Seventy-two percent (n=58) of the women reported a history of hormone use 
either for fertility, contraception or hormone replacement and 27.5% (n=22) denied any history 
of hormone use. Of the 61 women who responded to the question about family history of breast 
cancer, 77% (n=47) did not report a family history of breast cancer and 23% (n=14) reported a 
family history of breast cancer in a mother, grandmother, sister or aunt. 
 
Table 3 
Clinical History Characteristics (Frequency and Percentage) (N=82) 
Clinical History Frequency Percent 
Stage  (N=82)   
Stage 0 14 17.1% 
Stage I 43 52.4% 
Stage II 19 23.2% 
Stage III 6 7.3% 
Treatment (N=82)   
Radiation only 49 59.8% 
Radiation and Chemotherapy 33 40.2% 
Hormone Use (N=80)   
Yes 58 72.5% 
No 22 27.5% 
Family History of Breast Cancer (N=61)   
Yes 14 23.0% 
No 47 77.0% 
 
Social/Behavioral history including a history of smoking, alcohol use, beer, wine and 
liquor consumption and the number of days per week exercised was also studied. Tables 4 and 5 
describe the frequency and percentage for each of these variables.  Of the 78 women who 
responded to their frequency of exercise, 21 women (26.9%) reported no weekly exercise, 29 
women (34.6%) exercised 3 days per week or less and 30 women (38.4%) exercised 4 days per 
week or more.  The average number of days exercised was 2.77 (M = 2.77 SD + 2.62) days per 
week.  Of the 81 women who responded, the majority of the women were non-smokers (n=43, 
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53.1%), 43.2% (n=35) of the women reported being a former smoker and three women (3.7%) 
were current smokers. Eighty women who responded to the alcohol use question, 49 women 
(61.3%) reported drinking alcohol and 31 (38.8%) denied drinking alcohol. Regarding 
consumption of beer, 5 women (9.4%) reported being beer drinkers and 48 women (90.6%) were 
not, 27 women (47.4%) reported drinking wine and 30 women (52.6%) did not drink wine, lastly 
6 women (11.3%) reported drinking liquor and 47 women (88.7%) reported no liquor 
consumption. 
Table 4 
Social/Behavioral History (Frequency, Percentage, Mean and Standard Deviation)  
Social/Behavioral History Frequency Percent Mean SD 
Days of Exercise (N=78)    2.77 2.62 
0 days 21 26.9%  
1 days 5 6.4%  
2 days 10 12.8%  
3 days 12 15.4%  
4 days 11 14.1%  
5 days 9 11.5%  
6 days 4 5.1%  
7 days 6 7.7%  
Smoking History (N=81)    
Current Smoker 3 3.7%  
Former Smoker 35 43.2%  
Non-Smoker 43 53.1%  
 
 
Table 5 
Social/Behavioral History (Frequency and Percentage)  
Social/Behavioral History Frequency Percent 
Alcohol Consumption (N=80)    
Yes 49 61.3% 
No 31 38.8% 
Beer Consumption (N=53)   
Yes 5 9.4% 
No 48 90.6% 
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Table 5 Continued 
 
  
Wine Consumption (N=57)   
Yes 27 47.4% 
No 30 52.6% 
Liquor Consumption (N=53)   
Yes 6 11.3% 
No 47 88.7% 
 
Table 6 lists the means and standard deviations for all the continuous and discrete 
variables including the antecedent (non-modifiable trait factors), mediator variables (modifiable 
state factors) and the outcome variable fear of recurrence for the study sample of 82 women.   
Antecedent Variable 
The only continuous antecedent variable measured on a Likert-type scale is displayed in 
Table 6 was trait anxiety and was measured using the State Trait Anxiety Index.  The sample of 
82 women yielded a mean score of (M = 36.88 SD + 8.53).  Compared to the general population 
of women ages 50-69 (M = 31.79) (Spielberger et al., 1983) this corresponded to a z-score in the 
72nd percentile of the distribution of trait anxiety scores.  
Mediator Variables  
 The mediator variables (modifiable state factors) displayed in Table 6 included 
depression, perceived stress, state anxiety, pain, fatigue, sleep disturbances and fear of 
recurrence for the sample of 82 women.  Depression was measured using the Center for 
Epidemiologic Studies Depression Scale for this study sample yielding a mean score of (M = 
10.49 SD + 9.09).  Compared to the general population (M = 9.25) (Radloff, 1977) this 
corresponded to a z-score in the 55th percentile of the distribution of depression scores. 
Perceived stress was measured using the Perceived Stress Scale resulting in a mean score of (M = 
15.15 SD + 7.09). Compared to the general population (M = 11.9) (Cohen et al., 1983) this 
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corresponded to a z-score in the 68th percentile of the distribution of perceived stress scores.  
State anxiety was measured using the State Trait Anxiety Index resulting in a mean score of (M = 
33.71 SD + 11.39).  Compared to the general population of women ages 50-69 (M = 32.20) 
(Spielberger et al., 1983), this corresponds to a z-score in the 55th percentile of the distribution of 
state anxiety scores.  Thus on average, women in study scored modestly higher on psychological 
measures of anxiety, depression and stress compared to women of similar age in the general 
population.  Pain, fatigue and disturbed sleep were all measured using the subscales of the M.D. 
Anderson Symptom Inventory.  Pain yielded a mean score of (M = 1.90 SD + 2.26), fatigue 
resulted a mean score (M= 3.57 SD + 2.74) and sleep disturbances had a mean score of (M = 3.16 
SD + 3.18). Population comparisons were not available but based on instrument scales pain, 
fatigue and sleep appear to be low to moderate.  
Outcome Variable 
 Fear of recurrence was measured using the Concerns About Recurrence Scale that 
consists of two scales, Concerns About Recurrence Overall Fear (CARS overall fear) and 
Concerns About Recurrence Nature of Worry (CARS nature of worry).  Table 6 displays the 
results for the mean and standard deviations for the CARS overall fear (M = 11.11 SD + 4.89) 
and the CARS nature of worry (M = 32.41 SD + 22.31). Population comparisons were not 
available but based on the instrument scales revealing fear of recurrence overall and nature of 
fears were moderate. 
 In summary, the women in this study at baseline reported higher trait, state anxiety, 
depression and perceived stress than the general population and low to moderate symptoms of 
pain, fatigue and sleep disturbances. At baseline, the study participants expressed low to 
moderate concerns regarding fear of cancer recurrence (CARS overall fear and CARS nature of 
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worry).   
 
Table 6 
Antecedent, Mediator and Outcome Variables (Means and Standard Deviations) (N=82) 
Variable Range Mean SD 
 Trait Anxiety 24.00 to 63.00 36.88 8.53 
Depression .00 to 41.00 10.49 9.09 
Perceived Stress 2.00 to 33.00 15.15 7.09 
State Anxiety 20.00 to 70.00 33.71 11.39 
Pain .00 to 10.00 1.90 2.26 
Fatigue .00 to 10.00 3.57 2.74 
Sleep Disturbances .00 to 10.00 3.16 3.18 
Concerns About Recurrence Overall 
Fear 
 
4.00 to 24.00 
 
11.11 
 
4.89 
Concerns About Recurrence Nature of 
Worry 
 
.00 to 98.00 
 
32.41 
 
22.31 
 
 
Research Aim Number One 
 Research aim one explores the relationship between the antecedent variables (trait 
factors) and fear of recurrence (CARS overall fear and CARS nature of worry).  Table 7 and 8 
represents the Pearson’s and Spearman’s correlations conducted for the continuous and discrete 
antecedent variables and the outcome variable fear of recurrence (CARS overall fear).  The 
findings suggest statistical significance that age (r = -.236, p = .033) was negatively associated 
with fear of recurrence (CARS overall fear) meaning as age increases, fear of recurrence 
decreases.  In addition, trait anxiety (r = .433, p = .000) was positively associated with fear of 
recurrence (CARS overall fear), meaning as trait anxiety increases, fear of recurrence increases. 
Education, stage and exercise were not found to be associated with fear of recurrence in this 
study sample.  
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Table 7 
Correlations of Parametric Antecedent Variables and Concerns About Recurrence Overall Fear  
Antecedent Variables N Pearson (r) p-value 
 Age  82 -.236 .033 
Trait Anxiety 82 .433 .000 
Exercise 78 -.072 .534 
 
 
Table 8 
Correlations of Nonparametric Antecedent Variables and Concerns About Recurrence Overall 
Fear  
Antecedent Variables N Spearman (𝜌) p-value 
Education 82 -.152 .172 
Stage  82 .057 .610 
 
 Table 9 and 10 represents the Pearson’s and Spearman’s correlations conducted for the 
continuous and discrete antecedent variables within the demographics, clinical and 
social/behavioral history and the outcome variable fear of recurrence (CARS nature of worry).  
The findings suggest statistical significance that age (r = -.269, p = .015) was negatively 
associated with fear of recurrence (CARS nature of worry) meaning as age increases fear of 
recurrence (CARS nature of worry) decreases. Additionally, trait anxiety (r = .358, p = .001) was 
positively associated with fear of recurrence (CARS nature of worry) meaning as trait anxiety 
increases fear of recurrence (CARS nature of worry) increases.  Education, stage and exercise 
were not found to be associated with fear of recurrence in this study sample.  
 
Table 9 
Correlations of Antecedent Variables and Concerns About Recurrence Nature of Worry 
Antecedent Variables N Pearson (r) p-value 
 Age  82 -.269 .015 
 Trait Anxiety 82 .358 .001 
Exercise 78 -.042 .713 
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Table 10 
Correlations of Nonparametric Antecedent Variables and Concerns About Recurrence Nature of 
Worry  
Antecedent Variables  N Spearman (𝜌) p-value 
Education 82 -.184 .098 
Stage  82 .196 .078 
 
 
Analysis of variance (ANOVA) was used to evaluate the relationship between the 
categorical antecedent variable (non-modifiable trait factors) including race/ethnicity, marital 
status, employment status, treatment type, smoking, alcohol use, hormone use, family history of 
breast cancer and the outcome variable (fear of breast cancer recurrence). 
Table 11 displays the results for the means and standard deviations for the dependent 
variable fear of recurrence using the CARS overall fear scale and categorical antecedent 
variables (demographics).  The means were not significantly different for being White (M = 
11.27 SD + 4.45) and being non-White (M = 10.70 SD + 8.11) with a p-value of .635. Table 21 
displays the results for the means and standard deviations for the dependent variable fear of 
recurrence using the CARS overall fear scale and marital status.  The means were not 
significantly different for marital status, married (M = 11.50 SD + 4.57) and for not married (M = 
11.11 SD + 4.89) with a p-value of .292.  The means were not significantly different for 
employment status, employed (M = 11.73 SD + 4.39) and unemployed (M = 10.24 SD + 4.02) 
with a p-value of .175. 
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Table 11 
 ANOVA Demographics and Concerns About Recurrence Overall Fear 
Demographics N Mean SD 95% CI for Mean p-value 
Lower 
Bound 
Upper 
Bound 
Ethnicity and Race       
White 59 11.27 4.45 10.11 12.43  
Non-White 23 10.70 5.98 8.11 13.28  
Total 82 11.11 4.89 10.03 12.19 .635 
Marital Status       
Married 56 11.50 4.57 10.28 12.72  
Not Married 26 10.27 5.52 8.04 12.50  
Total 82 11.11 4.89 10.03 12.19 .292 
Employment       
Employed 48 11.73 4.39 10.17 13.29  
Unemployed 34 10.24 4.02 8.83 11.64  
Total 82 11.11 4.89 10.03 12.19 .175 
  C.I. = Confidence Interval 
  Note: Each variable evaluated separately 
 
 
Table 12 displays the results for the means and standard deviations for the dependent 
variable fear of recurrence using the CARS overall fear scale and the categorical antecedent 
variables (clinical history). Means were not significantly different by treatment type, radiation 
(M = 11.27 SD + 5.15) and for radiation and chemotherapy (M = 10.88 SD + 12.49) with a p-
value of .728.  The means were not significantly different for hormone use (M = 11.26 SD + 
5.07) and no hormone use (M = 11.00 SD + 4.66) with a p-value of .863.  The means were not 
significantly different for family history of breast cancer (M = 10.86 SD + 5.35) and no family 
history of breast cancer (M = 11.26 SD + 4.88) with a p-value of .794. 
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Table 12 
ANOVA Clinical History and Concerns About Recurrence Overall Fear 
Clinical History N Mean SD 95% CI for Mean p-value 
Lower 
Bound 
Upper 
Bound 
 
Treatment       
Radiation 49 11.27 5.15 9.79 12.74  
Radiation and 
Chemotherapy 
33 10.88 4.55 9.26 12.49  
Total 82 11.11 4.89 10.03 12.19 .728 
Hormone Use       
Yes 58 11.26 5.07 9.93 12.59  
No 22 11.00 4.66 8.93 13.07  
Total 80 11.19 4.93 10.09 12.28 .836 
Family History of Breast 
Cancer 
      
Yes 14 10.86 5.35 7.77 13.94  
No 47 11.26 4.88 9.82 12.69  
Total 61 11.16 4.95 9.90 12.43 .794 
  C.I. = Confidence Interval 
  Note: Each variable evaluated separately 
 
Table 13 and 14 displays the results for the means and standard deviations for the 
dependent variable fear of recurrence using the CARS overall fear scale and antecedent variables 
(social/behavioral history).  The means were not significantly different smoking history, 
currently smoking (M = 12.00 SD + 10.58), former smoker (M = 11.60 SD + 4.72) and non-
smoker (M = 10.72 SD + 4.91) with a p-value of .706.  The means were not significantly 
different for alcohol use (M = 10.84 SD + 4.58) and no alcohol use (M = 11.81 SD + 5.41) with a 
p-value of .393. The means were not significantly different for alcohol use, drinking beer (M = 
9.00 SD + 4.00) and not drinking beer (M = 11.50 SD + 4.92) with a p-value of .278; 
drinking wine (M = 10.48 SD + 4.22) and not drinking wine (M = 12.33 SD + 5.73) with a p-
value of .175; drinking liquor (M = 12.33 SD + 4.80) and not drinking liquor (M = 11.28 SD + 
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4.95) with a p-value of .623. 
Table 13 
ANOVA Social/Behavioral History and Concerns About Recurrence Overall Fear 
Social/Behavioral 
History 
N Mean SD 95% CI for Mean p-value 
 
Lower  
Bound 
 
Upper  
Bound 
Smoking History       
Current Smoker 3 12.00 10.58 -14.29 38.29  
Former Smoker 35 11.60 4.72 9.98 13.22  
Non-Smoker 43 10.72 4.70 9.27 12.17  
Total 81 11.15 4.91 10.06 12.23 .706 
  C.I. = Confidence Interval 
  Note: Each variable evaluated separately 
 
 Table 14 
 ANOVA Social/Behavioral History and Concerns About Recurrence Overall Fear 
Social/Behavioral 
History 
N Mean SD 95% CI for Mean p-value 
 
Lower 
Bound 
 
Upper  
Bound 
Alcohol Use       
Yes 49 10.84 4.58 9.52 12.15  
No 31 11.81 5.41 9.82 13.79  
Total 80 11.21 4.91 10.12 12.30 .393 
Beer Consumption       
Yes 5 9.00 4.00 4.03 13.97  
No 48 11.50 4.92 10.07 12.93  
Total 53 11.26 4.86 9.92 12.60 .278 
Wine Consumption       
Yes 27 10.48 4.22 8.81 12.15  
No 30 12.33 5.73 10.19 14.47  
Total 57 11.45 5.11 10.10 12.81 .175 
Liquor Consumption       
Yes 6 12.33 4.80 7.29 17.37  
No 47 11.28 4.95 9.82 12.73  
Total 53 11.40 4.90 10.05 12.75 .623 
  C.I. = Confidence Interval 
  Note: Each variable evaluated separately 
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Table 15 displays the results for the means and standard deviations for the dependent 
variable fear of recurrence using the CARS nature of worry scale and categorical antecedent 
variables (demographics). The means were not significantly different for being White (M = 31.89 
SD + 19.86) and non-White (M = 33.74 SD + 28.11) with a p-value of .738.  The means were not 
significantly different for marital status, married (M = 33.14 SD + 20.34) and unemployed (M = 
30.82 SD + 26.44) with a p-value of .664.  The means were not significantly different for 
employment status, employed (M = 33.69 SD + 24.43) and unemployed (M = 30.60 SD + 19.13) 
with a p-value of .540. 
Table 15 
 ANOVA Demographics and Concerns About Recurrence Nature of Worry 
Demographics N Mean SD 95% CI for Mean p-value 
Lower 
Bound 
Upper 
Bound 
Race and Ethnicity       
White 59 31.89 19.86 26.71 37.06  
Non-White 23 33.74 28.11 21.59 45.89  
Total 82 32.41 22.31 27.51 37.31 .738 
Marital Status       
Married 56 33.14 20.34 27.70 38.59  
Not Married 26 30.82 26.44 20.15 41.50  
Total 82 32.41 22.31 27.51 37.31 .664 
Employment Status       
Employed 48 33.69 24.43 26.59 40.78  
Unemployed 34 30.60 19.13 23.92 37.28  
Total 82 32.41 22.31 27.51 37.31 .540 
  C.I. = Confidence Interval 
  Note: Each variable evaluated separately 
 
 
Table 16 displays the results for the means and standard deviations for the dependent 
variable fear of recurrence using the CARS nature of worry scale and the categorical antecedent 
variables (clinical history). The means were not significantly different for treatment type, 
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radiation (M = 29.78 SD + 20.90) and radiation and chemotherapy (M = 36.30 SD + 24.05) with 
a p-value of .196. The means were not significantly different for hormone use (M = 32.21 SD + 
21.63) and no hormone use (M = 34.05 SD + 24.93) with a p-value of .747.  The means were not 
significantly different for family history of breast cancer (M = 31.36 SD + 22.89) and no family 
history of breast cancer (M = 33.29 SD + 23.14) with a p-value of .785. 
 
Table 16 
ANOVA Clinical History and Concerns About Recurrence Nature of Worry 
Clinical History N Mean SD 95% CI for Mean p-value 
Lower 
Bound 
Upper 
Bound 
Treatment        
Radiation 49 29.78 20.90 23.78 35.79  
Radiation and 
Chemotherapy 
33 36.30 24.05 27.78 44.83  
Total 82 32.41 22.31 27.51 37.31 .196 
Hormone Use       
Yes 58 32.21 21.63 26.53 37.90  
No 22 34.05 24.93 22.99 45.10  
Total 80 32.72 22.43 27.73 37.71 .747 
Family History of Breast 
Cancer 
      
Yes 14 31.36 22.89 18.14 44.58  
No 47 33.29 23.14 26.49 40.08  
Total 61 32.84 22.91 26.98 38.71 .785 
  C.I. = Confidence Interval 
  Note: Each variable evaluated separately 
 
Table 17 and 18 displays the results for the means and standard deviations for the 
dependent variable fear of recurrence using the CARS nature of worry Scale and antecedent 
variables (social/behavioral history). The means were not significantly different for currently 
smoking (M = 36.33 SD + 37.07), former smoker (M = 34.11 SD + 22.98) and non-smoker (M = 
30.78 SD + 21.46) with a p-value of .775; alcohol use (M = 30.06 SD + 21.58) and no alcohol 
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use (M = 36.79 SD + 23.61) with a p-value of .194; drinking beer (M = 24.60 SD + 15.87) and 
not drinking beer (M = 32.51 SD + 20.87) with a p-value of .416; drinking wine (M = 28.74 SD 
+ 18.86) and not drinking wine (M = 23.81 SD + 23.65) with a p-value of .221; and drinking 
liquor (M = 37.67 SD + 24.68) and not drinking liquor (M = 32.20 SD + 20.31) with a p-value of 
.547. 
 
Table 17 
ANOVA Social/Behavioral History and Concerns About Recurrence Nature of Worry 
Social/Behavioral 
History 
N Mean SD 95% CI for Mean p-value 
Lower 
Bound 
Upper 
Bound 
Smoking History       
Current Smoker 3 36.33 37.07 -55.76 128.43  
Former Smoker 35 34.11 22.98 26.22 42.00  
Non-Smoker 43 30.78 21.46 24.17 37.38  
Total 81 32.42 22.45 27.46 37.39 .775 
  C.I. = Confidence Interval 
  Note: Each variable evaluated separately 
 
 
Table 18 
ANOVA Social/Behavioral History and Concerns About Recurrence Nature of Worry 
Social/Behavioral 
History 
N Mean SD 95% CI for Mean p-value 
Lower 
Bound 
Upper  
Bound 
Alcohol Use       
Yes 49 30.06 21.58 23.86 36.26  
No 31 36.79 23.61 28.13 45.45  
Total 80 32.67 22.48 27.66 37.67 .194 
Beer Consumption       
Yes 5 24.60 15.87 4.90 44.30  
No 48 32.51 20.87 26.45 38.57  
Total 53 31.76 20.46 26.12 37.40 .416 
Wine Consumption       
Yes 27 28.74 18.86 21.28 36.20  
No 30 35.81 23.65 26.98 44.64  
Total 57 32.46 21.62 26.72 38.20 .221 
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Table 18 Continued 
 
      
Liquor Consumption       
Yes 6 37.67 24.68 11.77 63.57  
No 47 32.20 20.31 26.24 38.16  
ANOVA Continued       
Total 53 32.82 20.65 27.13 38.51 .547 
  C.I. = Confidence Interval 
  Note: Each variable evaluated separately 
 
 
Aim one explored the relationship between the antecedent variables (trait factors) that 
are typically non-modifiable attributes associated with fear of recurrence (CARS overall fear 
and CARS nature of worry) using Pearson’s and Spearman’s correlations and analysis of 
variance (ANOVA). The findings revealed that age was negatively associated with overall fear 
of recurrence (r = -.236, p = .033) and fear of recurrence nature of worry (r = -.269, p = .015). In 
addition, trait anxiety was associated with overall fear of recurrence (r = .433, p = .000) and fear 
of recurrence nature of worry (r = .358, p = .001).  Race/ethnicity, education, marital status, 
employment, exercise, stage, treatment, exercise, smoking, drinking, hormone use and family 
history of breast cancer were not found to be associated with fear of recurrence in this study 
sample. 
Research Aim Two 
 
  A univariate analysis was examined by correlation coefficients for continuous covariates 
to evaluate the relationship between mediator variables (modifiable state factors) - psychological 
symptoms such as state anxiety, depression, perceived stress and physiological symptoms such 
as pain, fatigue, sleep disturbances and the outcome variable (fear of breast cancer recurrence).  
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The dependent variable of interest, fear of breast cancer recurrence, was measured on continuous 
scale using Pearson’s correlations.  
 Table 19 represents the Pearson’s correlations conducted for the continuous mediator 
variables and the outcome variable fear of recurrence (CARS overall fear).  The findings reveal 
statistical significance that depression (r = .347, p = .001), state anxiety (r = .467, p = .000) and 
perceived stress (r = .365, p = .001) were positively associated with fear of recurrence (CARS 
overall fear). 
 
Table 19 
Correlations of Mediator Variables and Concerns About Recurrence Overall Fear (N=82) 
Mediator Variables Pearson (r) p-value 
Pain .202 .069 
Fatigue .114 .308 
Sleep disturbances .162 .145 
Depression .347 .001 
State Anxiety .467 .000 
Perceived Stress .365 .001 
 
Table 20 represents the correlations for the continuous mediator variables and the 
outcome variable, concerns about recurrence nature of worry.  Pearson’s correlations conducted 
for the continuous mediator variables and the outcome variable fear of recurrence (CARS nature 
of worry).  The findings reveal statistical significance that pain (r = .220, p = .047), fatigue (r = 
.247, p = .025), state anxiety (r = .369, p = .001) and perceived stress (r = .410, p = .000) were 
positively associated with fear of recurrence (CARS nature of worry). 
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Table 20 
Correlations of Mediator Variables and Concerns About Recurrence Nature of Worry (N=82) 
Mediator Variables  Pearson (r) p-value 
Pain .220 .047 
Fatigue .247 .025 
Sleep .118 .292 
Depression .213 .055 
State Anxiety .369 .001 
Perceived Stress .410 .000 
 
Aim two explored the relationship between the mediator variables (state factors), 
typically modifiable attributes such as pain, fatigue, sleep disturbances, state anxiety, depression, 
perceived stress associated with fear of recurrence (CARS overall fear and CARS nature of 
worry) using Pearson’s correlations. Findings revealed that depression (r = .347, p = .001), state 
anxiety (r = .467, p = .000), perceived stress (r = .365, p = .001) were associated with overall fear 
of recurrence and pain (r = .220, p = .047), fatigue (r = .247, p = .025), state anxiety (r = .369, p 
= .001), and perceived stress (r = .410, p = .000) were associated with fear of cancer recurrence 
nature of worry.  
Research Aim Three 
Aim three assessed potential mediation effects of the mediating variables (modifiable 
state factors), meaning the indirect effect of these variables on the direct relationship between 
antecedent variables (non-modifiable trait factors) and the primary outcome variable, fear of 
breast cancer recurrence.  In this analysis, antecedent (trait) factors are assumed to have both a 
direct (c' path) and indirect path (a path) to the outcome of fear of breast cancer recurrence 
through the mediator variable (b path).  
 The linear regression method described by Preacher and Hayes (2008) was used to assess 
the indirect effects of potential mediators in a simple mediation model. This approach was used 
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to determine whether the specific state factors that were most correlated with fear of recurrence 
(state anxiety, perceived stress and depression) mediated the relationship between the antecedent 
(non-modifiable trait) factors that were most correlated with fear of recurrence.  Given that age 
and trait anxiety were correlated with both fear of recurrence scales (CARS overall fear and 
CARS nature of worry), it was determined that having a single antecedent variable and one 
mediator variable with the outcome variable would allow for the most reliable and interpretable 
assessment of mediation.   Therefore, in addition to examining age and trait anxiety separately as 
antecedent variables, a composite of these 2 variables was created. Specifically, the standardized 
Z-score for each variable was obtained and summed, thereby providing equal weight for the 2 
variables combined in a single variable. This composite antecedent variable (age/trait anxiety) 
was analyzed in separate mediation models with fear of recurrence for both CARS overall fear 
and CARS nature of worry.  Because of the relatively modest sample size, bootstrapping with 
5,000 iterations was used to obtained unbiased estimates, to the extent possible, of the indirect 
effects of the potential mediating variables.  
The findings in Table 21 indicate that state anxiety mediates the relationship (has an 
indirect effect) between trait anxiety and fear of recurrence (CARS overall fear). For these 
results, the notation βa1b1 is used to denote the unstandardized beta coefficient for the mediating 
variable representing the previously depicted a à b à Y path (i.e. indirect effect). With trait 
anxiety as the antecedent variable, the indirect effect of state anxiety is statistically associated 
with CARS overall fear (β = .1381, 95% CI = .0053 - .3050, p = .0299). Similarly, with the 
composite age/trait anxiety antecedent variable, state anxiety is statistically associated with 
CARS overall fear (β = .5579, 95% CI = .1201 - 1.1669, p = .0157).  The standardized z- scores 
for state anxiety were 2.1718 and 2.4159 respectively for the models with trait anxiety alone 
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versus the composite z-score of age/trait anxiety as the antecedent variable.  Therefore, inclusion 
of age with trait anxiety nominally influenced (improved) the strength of relationship with fear of 
recurrence (CARS overall fear), as well as the indirect effect of state anxiety. Perceived stress 
and depression were not statistically significant, and did not provide evidence of mediating the 
relationship between trait anxiety, age/trait anxiety and concerns about recurrence (CARS overall 
fear).   
 
Table 21 
Indirect Effects of Antecedent Variables on Concerns About Recurrence Overall Fear through 
Mediator Variables (ab paths) (N = 82) 
Variables β Coefficient SE z p-value 
Antecedent Variable Mediator Variable     
Age  State Anxiety -.0046 .0275 -.1682 .8664 
Trait Anxiety State Anxiety .1381 .0636 2.1718 .0299* 
Trait Anxiety and Age ** State Anxiety .5579 .2309 2.4159 .0157* 
Age Perceived Stress -.0144 .0211 -.6804 .4962 
Trait Anxiety Perceived Stress .0517 .0530 .3288 .3288 
Trait Anxiety and Age** Perceived Stress .2897 .2191 1.3221 .1861 
Age Depression .0029 .0209 .1373 .8908 
Trait Anxiety Depression .0284 .0608 .4670 .6405 
Trait Anxiety and Age** Depression .2521 .2028 1.2433 .2137 
* p < .05 
S.E. = Standard Error 
 **Composite variable - converted to z-score to apply equal weight to each variable 
Note: Each model evaluated separately  
 
The findings in Table 22 indicate that perceived stress mediates the relationship (has an 
indirect effect) between trait anxiety and fear of recurrence (CARS nature of worry). For these 
results, the notation βa1b1 is used to denote the unstandardized beta coefficient for the mediating 
variable representing the previously depicted a à b à Y path (i.e. indirect effect). With trait 
anxiety as the antecedent variable, the indirect effect of perceived stress is statistically associated 
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with CARS nature of worry (β = .5474, 95% CI = .0178 - 1.3298, p = .0294). Similarly, with the 
composite age and trait anxiety antecedent variable, perceived stress is statistically associated 
with concerns about recurrence nature of worry (β = 2.0375, 95% CI = .1136 - 4.5976, p = 
.0495).  The standardized regression coefficients for perceived stress were 2.1787 and 1.9644 
respectively for the models with trait anxiety alone versus the composite z-score of age/trait 
anxiety as the antecedent variable.  Therefore, inclusion of age with trait anxiety had no 
incremental increase in the strength of relationship with fear of recurrence (CARS nature of 
worry), as well as the indirect effect of perceived stress. State anxiety, fatigue and pain were not 
statistically significant, and did not provide evidence of mediating the relationship between trait 
anxiety, age/trait anxiety and concerns about recurrence (CARS nature of worry). 
Table 22 
Indirect Effects of Antecedent Variables on Concerns About Recurrence Nature of Worry 
through Mediator Variables (N = 82) 
Variables β Coefficient SE z p-value 
Antecedent Variable Mediator Variable     
Age  State Anxiety -.0166 .0989 -.1681 .8665 
Trait Anxiety State Anxiety .4470 .3012 1.4844 .1377 
Trait Anxiety and Age ** State Anxiety 1.5524 1.0356 1.4990 .1339 
Age Perceived Stress -.0735 .1075 -.6837 .4941 
Trait Anxiety Perceived Stress .5474 .2512 2.1787 .0294* 
Trait Anxiety and Age** Perceived Stress 2.0375 1.0372 1.9644 .0495* 
Age Fatigue -.0318 .0646 -.4927 .6223 
Trait Anxiety Fatigue .0915 .0736 1.2430 .2139 
Trait Anxiety and Age** Fatigue .4804 .4076 1.1785 .2386 
Age Pain -.0005 .0595 -.0083 .9934 
Trait Anxiety Pain .0862 .0746 1.1563 .2476 
Trait Anxiety and Age** Pain .3867 .3656 1.0577 .2902 
* p < .05.  
S.E. = Standard Error 
 **Composite variable - converted to z-score to apply equal weight to each variable 
Note: Each model evaluated separately  
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Summary of Findings 
 After accounting for the direct effects (c' path = a, b, c paths) of trait anxiety and trait 
anxiety and age combined on fear of cancer recurrence (CARS overall fear and CARS nature of 
worry) two significant mediation effects were identified.  This included state anxiety mediating 
the relationship between trait anxiety and fear of recurrence (CARS overall fear), and perceived 
stress mediating the relationship between trait anxiety and fear of recurrence (CARS nature of 
worry). Whereas similar results were observed when trait anxiety and age were combined as a 
composite antecedent variable, the results appeared to be driven principally by the effect of trait 
anxiety with age adding little to the strength of the relationships. In aggregate, these findings 
suggest that the women in this study who had a history of trait anxiety (and perhaps of younger 
age) were more likely to experience fear of cancer recurrence (CARS overall) if they also were 
experiencing anxious symptoms in their current state (state anxiety). Additionally, those women 
in this study who had a history of trait anxiety (and perhaps of younger age) were more likely to 
experience fear of cancer recurrence (CARS nature of worry) if they were also experiencing 
stressful feelings about their life within the past month (perceived stress). 
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Chapter Five 
Discussion, Conclusions and Recommendations 
Introduction 
 This final chapter presents the synthesis of the research results including the discussion of 
the findings, conclusions, implications and recommendations for future study.  This study 
explored non-modifiable trait and modifiable factors state factors most associated with fear of 
breast cancer recurrence and the mediating relationship between those variables.  The intent was 
to establish an understanding of how particular trait and state characteristics can influence a 
patient’s concern about the recurrence of their cancer.  Understanding this relationship supports 
the opportunity for health care providers to offer interventions to those patients at risk for greater 
fears of recurrence.  
Summary of the Study 
 A cross-sectional research design was used to conduct a secondary data analysis among 
82 women who were post-treatment for breast cancer. The original parent study was an R-21 
NCI funded, randomized controlled intervention trial examining the Effects of Mindfulness 
Based Stress Reduction in Early Stage Breast Cancer Recovery (Lengacher et al., 2009). The 
current study utilizes the baseline data from the R-21 study for a secondary data analysis 
examining the relationship between trait factors and state factors on fear of cancer recurrence in 
breast cancer survivors. 
The study sample consists of 82 out of 84 women age 21 or older who were diagnosed 
with breast cancer Stage 0, I, II, III and had undergone lumpectomy and received adjuvant 
 
 
75 
radiation and/or chemotherapy and were within 18 months post treatment.  Other inclusion 
criteria included the ability to read and speak English at an 8th grade level in order to respond to 
survey questions.  Several recruitment methods were used including introduction of the study by 
healthcare practitioners at the H. Lee Moffitt Cancer Center in addition to brochures and flyers 
distributed throughout the cancer center.  Patients who expressed interest in the study were asked 
to complete a HIPAA authorization form that indicated their willingness to be contacted by a 
member of the trained research team.  Interested subjects were provided with an orientation 
session within 18 months post treatment for breast cancer, considered to be the transition period 
from conventional treatment to the adaptation and return to routine daily life and activities.  
During the orientation session study details were explained, informed consent was obtained, and 
patients were randomized into the different groups (as a note, in order to maximize enrollment 
subjects who were randomized to the control group were offered the opportunity to receive the 
intervention after a wait period). 
Discussion and Conclusion 
Descriptive data were obtained for the demographics of the study sample including 
frequencies, percentages, means and standard deviations.  The mean age of the women in the 
study was of 57 years (M = 57.18 SD + 9.136). Eighty seven percent of the study participants 
were White and 12.2% were Black non-Hispanic. The majority of the women who participated in 
the study were married (68.3%) and 31.7% were unmarried divorced, never married or separated. 
Fifty eight percent of the women were employed at the start of the study and the majority of the 
women (67.1%) reported some level of higher education (n=55) including college, graduate 
school or professional school.  
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Clinical history revealed that the majority of the women were diagnosed with early stages 
of cancer, Stage 0 (17.1%) and Stage I (52.4%) with 59.8% received radiation only and 40.2% 
received radiation and chemotherapy.  Fifty-eight women reported a history of hormone use 
either for fertility, contraception or hormone replacement and 14 women reported a family 
history of breast cancer in a mother, grandmother, sister or aunt. 
Social/Behavioral history including a history of smoking, alcohol use, beer, wine and 
liquor consumption and the number of days per week exercised was also studied. The average 
number of days exercised was 2.77 days per week.  Of the 81 women who responded, the 
majority of the women were non-smokers (53.1%), 43.2% of the women reported being a former 
smoker and 3.7% were current smokers. Of the 80 responses to alcohol consumption, 49 women 
(61.3%) reported drinking alcohol with wine being predominating beverage of choice over beer 
and liquor.  
In this study sample, the women demonstrated higher levels of perceived stress, state and 
trait anxiety, and depression compared to the general population. Overall, the women in the 
study experienced low pain scores and low to moderate fatigue, sleep disturbance levels and fear 
of recurrence. 
Research aim one explored the relationship between the antecedent variables (non-
modifiable trait factors) and fear of recurrence (CARS Overall and CARS Nature).  The findings 
revealed statistical significance that age was negatively associated with fear of recurrence 
(CARS overall fear (r = -.236, p = 0.033) and CARS nature of worry (r = -.269, p = .015)) 
meaning as age increases, fear of recurrence decreases which consistent with the literature 
(Connell et al., 2006; Crane-Okada et al., 2012; Janz et al., 2011; King et al., 2000; McGinty et 
al., 2010; Thewes et al., 2012; Van den Beuken-van Everdingen et al., 2008; Waljee et al., 2008).  
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In addition, trait anxiety was positively associated with fear of recurrence (CARS overall fear (r 
= .433, p=.000) and CARS nature of worry (r = .358, p = .001)), meaning as trait anxiety 
increases, fear of recurrence increases. Several studies discovered similar findings, suggesting 
perhaps a bidirectional relationship between anxiety and fear of cancer recurrence (Corter et al., 
2013; Costanzo et al., 2007; Crane-Okada et al., 2012; Liu et al., 2011; Young & White, 2006; 
Ziner et al., 2012).  Education, stage and exercise were not found to be associated with fear of 
recurrence for CARS overall worry or CARS nature of worry.  The analysis of variance 
(ANOVA) did not reveal any significant differences between the groups for the categorical 
antecedent variables (race/ethnicity, marital status, employment, treatment type, hormone use, 
family history of cancer, smoking, alcohol use) and the outcome variable fear of recurrence   
(CARS overall fear and CARS nature of worry). 
Research aim two used Pearson’s correlations to examine the relationship between 
mediator variables (modifiable state factors) - psychological symptoms such as state anxiety, 
depression, perceived stress and physiological symptoms such as pain, fatigue, sleep 
disturbances and the outcome variable fear of breast cancer recurrence (CARS overall fear and 
CARS nature of worry).  The findings yielded statistical significance for depression (r = .347, p 
= .001), state anxiety (r = .467, p = .000) and perceived stress (r = .365, p = .001) as having a 
positive association with fear of recurrence (CARS overall fear). These results support findings 
from several others studies that women who experience psychological distress (depression, 
anxiety, perceived stress) are at greater risk for overall fear of cancer recurrence (Allen et al., 
2009; Corter et al., 2013; Costanzo et al., 2007; Crane-Okada et al., 2012; Liu et al., 2011; 
Taylor et al., 2011; Young & White, 2006; Ziner et al., 2012). Analysis of fear of cancer 
recurrence (CARS nature of worry) revealed statistical significance for pain (r = .220, p = .047), 
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fatigue (r = .247, p = .025), state anxiety (r = .369, p = .001) and perceived stress (r = .410, p = 
.000) as having a positive association. Pain and fatigue were observed to be associated with fear 
of recurrence throughout the literature, sometimes referred to as “triggers” these symptoms can 
create a great deal of distress for breast cancer survivors triggering fears of recurrence (Allen et 
al., 2009; Clayton et al., 2006; Corter et al., 2013; Ferrell et al., 1997; Grimsbo et al., 2011; Janz 
et al., 2011; Van den Beuken-van Everdingen et al., 2008; Vickberg, 2001; Young & White, 
2006; Ziner et al., 2012) 
Research aim three assessed mediating state variables (transient, modifiable state factors) 
indirect (mediation) effect on the relationships between antecedent trait variables (stable, non-
modifiable trait factors) and the outcome variable fear of breast cancer recurrence.  Antecedent 
(trait) factors are assumed to have both a direct (c' path) and indirect path (a path) to the outcome 
of fear of breast cancer recurrence through the mediator variable (b path).  
These findings suggest a statistical significance of the indirect effect of state anxiety on 
trait anxiety and the composite variable of trait anxiety/age related to fear of recurrence (CARS 
overall fear).  The standardized Z-scores for state anxiety were slightly increased for trait anxiety 
and for the composite variable of age/trait anxiety suggesting that state anxiety is a mediator of 
trait anxiety and age/trait anxiety and fear of recurrence (CARS overall fear).  
The findings related to CARS nature of worry indicate that perceived stress mediates the 
relationship between trait anxiety and fear of recurrence (CARS nature of worry). These findings 
suggest a statistical significance of the indirect effect of perceived stress on trait anxiety and the 
composite variable trait anxiety/age related to fear of recurrence (CARS nature of worry).  The 
standardized Z-scores for perceived stress were reduced for trait anxiety and for age/trait anxiety 
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combined suggesting that perceived stress is a partial mediator of trait anxiety and age/trait 
anxiety combined and fear of recurrence (CARS nature of worry).  
The significance of these findings suggest that women who are anxious at baseline and 
experiencing or at risk for experiencing situational anxiety are at greater risk of overall fears of 
breast cancer recurrence.  Given the relationship between age, trait anxiety and fear of 
recurrence, younger women could be particularly vulnerable for overall fear of breast cancer 
recurrence.  Similarly, women who are anxious at baseline and are experiencing situations in 
their life that they perceive to be stressful may be at greater risk for worries related to fear of 
recurrence such as health worries, role worries, womanhood worries and death worries. As was 
discussed with the relationship between trait anxiety and fear of recurrence, the findings suggest 
in this study that younger survivors who are experiencing perceived stressful situations in their 
life and anxiety at baseline may be at greater risk for fear of breast cancer recurrence. 
The relevance of these findings rests in the research to date that has explored the 
outcomes of psychological distress in cancer survivorship in relation to survivorship well-being, 
quality of life and utilization of health care resources (Barsky et al., 2001; Ferrell et al., 1997; Gil 
et al, 2005; Grimsbo et al., 2011; King et al., 2000; Lebel et al., 2007; Lebel et al., 2013; Taylor 
et al., 2011; Vickberg, 2003; Young & White, 2006).  The research to date highlights the reality 
that breast cancer survivors experience life-long emotional sequelae from their cancer diagnosis 
and treatment including the concerns that their cancer will return.  What is less clear is how to 
best prepare patients for survivorship, including evidenced based methods for risk screening 
regarding those physiological and psychological traits and states, like anxiety, perceived stress 
and fear of recurrence, which may have an impact on survivorship.   
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In summary, this study was performed utilizing a cross-sectional quantitative research 
design analyzing secondary data from a previously conducted randomized controlled trial. The 
Logic Model provided a heuristic framework to examine the associations between trait factors 
and state factors and the mediating effects on fear of breast cancer recurrence.  Relationships 
between the antecedent variables (trait factors) typically considered stable non-modifiable 
attributes (demographic, clinical history, social/behavioral) with fear of recurrence (CARS 
overall fear and CARS nature of worry) were examined using Pearson’s and Spearman’s 
correlations and analysis of variance (ANOVA).   Secondly, the relationship between the 
mediator variables (state factors), typically considered to be transient and modifiable attributes 
such as pain, fatigue, sleep disturbances, state anxiety, depression, perceived stress were 
examined to determine their associations with fear of recurrence (CARS overall fear and CARS 
nature of worry) using Pearson’s correlations. The final step of analysis employed a mediation 
model to examine the indirect effects of the statistically significant modifiable state factors on 
the statistically significant antecedent trait factors and fear of recurrence (CARS overall fear and 
CARS nature of worry).  
Limitations 
  This study provided preliminary findings related to factors that may interfere with the 
psychological well-being and recovery of breast cancer survivors. Understanding these 
relationships can help health care providers initiate meaningful interventions to optimize the 
well-being and quality of life in survivorship.  Limitations of this study may include: 
1. The sample size of 82 women limits the strength and generalizability of the findings. 
2. The study participants were a homogeneous sample of women enrolled from only one 
site in the Tampa Bay area of Florida limiting the generalizability to other populations. 
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3. The use of paper and pencil questionnaires may enhance measurement error. 
4. The use of more discrete measurement instruments (for example: the Brief Pain Invetory) 
could be used to measure physiologic symptoms (pain, fatigue, sleep disturbances). 
Implications for Nursing 
 The findings from this study suggest that breast cancer survivors who are anxious at 
baseline and report a current state of anxiety or perceived stress (current situations in their life 
that are deemed to be stressful) may be at higher risk for fears of breast cancer recurrence.  The 
implications of this research for nursing are merely to recognize the existence of these 
relationships and how they pertain to their patients. Understanding those individual patient 
characteristics such as age, history of anxiety and current status of perceived stress or anxiety 
and the relationship with fears of recurrence will allow nurses to offer individualized 
interventions to those patients at greatest risk for psychological distress.  These findings also 
support the need to for further exploration of the unique survivorship needs of different patient 
populations based on their demographics, social, behavioral and clinical history.  
Early screening of those risk factors for fear of recurrence and identification of patients at 
greatest risk along with multimodal options for intervention can optimize well-being and quality 
of life thus reducing unnecessary distress.  The findings add to advancing the science associated 
with fear of recurrence and breast cancer survivorship.  As the generation of cancer survivors 
continues to grow, addressing the psychological and physiological long-term survivorship needs 
becomes imperative.   
 
 
 
 
 
82 
Recommendations for Future Study 
 The following recommendations for future research are based upon review of the relevant 
research and findings from the current study: 
1. Replicate this research utilizing the subscales within the CARS nature of worry scale to 
further understand more specifically the mediation of effect and relationship between trait 
anxiety, perceived stress and fear of recurrence. 
2.  Due to the limited size and diversity of the current study sample, expanding the study of 
fear of recurrence to include intervention research in ethnically diverse and international 
populations at risk for fear of breast cancer recurrence.  
3. Study the implementation of early screening and interventions that address, anxiety and 
perceived stress, which are strongly associated with fear of breast cancer recurrence with 
the goal of improving the psychological health, well-being and overall quality of life in 
breast cancer survivorship.   
4. Identify and test best practices for risk screening and ongoing support models that include 
ongoing access to survivorship information and education, integrative/complimentary 
medicine and social support programs to reduce psychological distress associated with 
anxiety, perceived stress and fear of recurrence. 
5. Study the effectiveness of anxiety, perceived stress and fear of recurrence intervention 
programs impact on psychological distress and health care utilization.     
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